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ABSTRACT
Oncology nurses are at risk for moral distress when providing routine care. Nurses have
reported barriers in delivering optimal pain relief and distress when giving chemotherapy to
patients that are seriously ill. Although this situation can escalate moral distress in the nurse,
some nurses have become stronger advocates for their patients. Moral distress is described as a
perceived threat to one’s values or identity that can inhibit the individual from pursuing the right
course of action. As such, nurses who experience high levels of moral distress and repeated
encounters may be more likely to have moral distress residue and leave a current position for one
less stressful. Moral distress residue is cumulative or unresolved distress. How nurses take a
stand or demonstrate moral courage during times of distress is not well understood. Therefore,
this study was undertaken to examine relationships between moral distress, moral distress
residue, and moral courage and to identify nurse characteristics that were predictors of moral
distress and moral courage. For this mixed method, non-experimental correlation design,
qualitative methods were used to expand quantitative results. Oncology nurses (n=187) working
in inpatient and outpatient settings were recruited through the National Oncology Nursing
Society in the Southeastern United States. Hamric’s 21-item Moral Distress Scale-Revised
(MDS-R) and Sekerka et al. 15-item Professional Moral Courage Scale were used for data
collection. Findings from this study show that work setting and having left a previous job were
predictors of moral distress but total years’ experience in oncology was predictive of moral
courage. Moral courage was displayed in major areas of supporting the patient, risk taking,
advocacy, enlarging the circle for decision-making, putting aside personal beliefs, respecting
patient autonomy, empowering the patient, fighting for the patient in the face of consequences in
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a complex system, sharing information, getting to the meaning, handling tricky situations,
protecting the patient and truth-telling. Despite experiencing levels of moral distress, oncology
nurses demonstrate support and respect for patients’ decision-making and autonomy. Ethics
education derived from clinical practice can provide an opportunity for open discussion for
nurses to create and maintain morally acceptable work environments that enable them to be
morally courageous. This research underscores the presence of moral distress and moral distress
residue among oncology nurses and the importance of finding ways to lessen moral distress and
strengthen moral courage in nurses.
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CHAPTER ONE: INTRODUCTION

Background
Oncology nurses play a fundamental role in caring for people with cancer (Ferrell &
Coyle, 2008). The relief of suffering is at the core of caring, and oncology nurses alleviate
suffering by means of a caring relationship, empowering patients and supporting the
patient/family connection throughout cancer treatment (Iranmanesh, Axelsson, Savenstedt, &
Haggstrom, 2009). Nurses in oncology strive to relieve pain, maintain open and honest
communication, and collaborate substantially to improve patient-outcomes (Pavlish, BrownSaltzman, Jakel, & Fine, 2014). Medicare reimbursement patterns in the last few weeks of a
patient’s life show that many cancer patients receive high-intensity treatments despite facing a
terminal disease and poor prognosis (Morden et al., 2012). Medicare reimburses all aspects of
cancer care such as paying separately for physician services, laboratory tests, procedures,
imaging, radiation, drug administration and hospital admissions for adverse outcomes (Bach,
2007). The high costs of new chemotherapy drugs and provider incentives that have favored
aggressive and costly treatments rather than alternative approaches may be driving this pattern
(Bach, 2007; Miller, 2015).
Many factors contribute to the patterns that affect the cost of cancer care, including
patient, family or provider preferences and opportunities exist to reduce spending that do not
involve denying patients access to life-saving treatments (Miller, 2007). Deciding when to stop
chemotherapy can be challenging because both patients and providers may think that ending
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treatment is the same as giving up hope or abandoning the patient (Buiting, Rurup, Wijsbek, van
Zuylen, & den Hartogh, 2011). However, a different problem occurs when a patient’s preference
for care does not align with the goals of therapy. Nurses are often caught in the middle of this
conflict and experience moral distress when patients, families, and the medical team disagree
about treatment (Ferrell & Coyle, 2008). An association exists between nurses’ own suffering
and the suffering witnessed in their patients (Ferrell & Coyle, 2008). When the patient’s
autonomy and preference for care conflicts with the goals of members of the treatment team,
oncology nurses are usually the first to know and may become distressed if their efforts to
advocate for and alleviate pain and suffering are perceived as ineffective in the treatment plan.
Another factor that may promote moral distress rather than moral courage is a perceived power
imbalance between physicians and nurses that may make it difficult for a nurse to take a stand
against futile treatment. For example, when power imbalances exist, a nurse may feel that she
cannot exercise autonomy or contribute to clinical decision-making which can have a negative
impact on patient outcome (Kim, Nicotera, McNulty, 2015; Papathanassoglou, Karanikola,
Kalafati, Giannakopoulou et al., 2012).
The oncology setting is the most cited with regards to nurses’ suffering associated with
cancer pain and death (Ferrell & Coyle, 2008). Nurses are at risk for moral distress when they
encounter barriers to what they perceive as optimal patient outcomes, such as minimizing harm
to patients or providing adequate pain control and good end-of-life care (Bernhofer & Sorrell,
2014; Corley, 2002; LeBaron, Beck, Black, & Palat, 2014). Moral distress is described as a
perceived threat to one’s core values or identity that inhibits the individual from taking the right
course of action (Corley, 2002; Epstein & Hamric, 2009; Jameton, 1984). Nurses who have
frequent encounters with morally challenging situations where they are not able to take their
2

perceived morally right action may have higher levels of distress. Nurses who are not able to
alleviate the distress may have cumulative effects or moral distress residue (Hamric, 2012).
Studies have shown that higher levels of moral distress or moral residue were present in nurses
who left a job or considered leaving a previous job (Hamric, 2012). Thus, having left a job or
considered leaving a previous job due to moral distress is an indirect or proxy indication of moral
distress residue (A.B. Hamric, personal communication, November 9, 2014). Moral distress
residue is the residual effect of compromising one’s perceived moral or ethical duty (Epstein &
Hamric, 2009; Jameton, 1993; Webster & Bayliss, 2000).
Study findings on moral distress have shown nurses’ weakness and suffering (Ferrell,
2006; Gutierrez, 2005), but how nurses elicit inner strength or moral courage during times of
distress has not been investigated. Moral courage is needed to take moral action so that nurses
can uphold their moral duty and accept moral challenges with integrity (Sekerka, Bagozzi, &
Charnigo, 2009). While previous studies have examined moral distress in nurses, the
relationship between moral distress and moral courage in oncology nurses working in the adult
oncology inpatient and outpatient settings has not been studied. The conceptual framework was
proposed to guide the study and to examine the relationship between moral distress, moral
distress residue, and moral courage.
The frequency with which nurses encounter morally challenging situations and barriers to
optimal patient care could be the catalyst for moral distress (Corley, 2002) or moral courage.
Studies have reported high levels of moral distress in nurses who witness the delivery of
medically ineffective interventions (Elpern, Covert, & Kleinpell, 2005; Ferrell, 2006; Gutierrez,
2005; Maningo-Salinas, 2010; Sirilla, 2014). An intervention can be perceived as medically
futile when its goals are not attainable or the degree of success is suboptimal and prolongs the
3

dying process rather than restoring health (Coppa, 1996; Meltzer & Huckabay, 2004; Mobley,
Rady, Verheijde, Patel, & Larson, 2007). Nurses who provide what they perceive as overly
aggressive treatments near end-of-life may consciously object and silently suffer in such care
(Ferrell, 2006; Hamric & Blackhall, 2007; Wiegand & Funk, 2012) or they may take a moral
stand. According to a study by Gutierrez (2005), nurses in a critical care unit did not want to be
assigned to the care of a patient whose medical situation they judged to be overly aggressive and
medically futile. Nurses with high moral distress levels also reported physical and emotional
symptoms, avoidance behavior, and fewer interactions and communication with providers,
patients and family (DeVillers, & DeVon, 2012; Elpern, Covert, & Kleinpell, 2005; Gutierrez,
2005; LeBaron, Beck, Black, & Palat, 2014).
Physical symptoms associated with moral distress in nurses included insomnia,
headaches, and stomach aches (Ferrell, 2006; Gutierrez, 2005; McClendon & Buckner, 2007;
Wiegand & Funk, 2012). Emotional symptoms included stress, anxiety, guilt, frustration, and
burnout (Gutierrez, 2005; McClendon & Buckner, 2007). Consequently, moral distress has the
potential to alter the quality of care and impact patient safety (Austin, 2012; Gutierrez, 2005;
Maiden, Georges, & Connelly, 2011; Wiegand & Funk, 2012). The negative consequences of
nurses’ moral distress have not been evaluated in patients or families, but nurses have perceived
indirect consequences such as fewer interactions and delayed care to the patients and families
(Gutierrez, 2005; Rice et al., 2008; Wiegand & Funk, 2012).
The literature on moral distress presents barriers to taking action when moral distress
occurs and introduces strategies for reducing moral distress (American Association of Critical
Care Nurses, 2006). However, missing from the literature is whether ethics education has been
effective in reducing moral distress and how nurses take a stand to assume their moral challenges
4

with integrity. Moral courage is described as the capacity to overcome fear by standing up for
one’s core values, and disposition to speak out or to take action in an assertive and principled
manner (Lachman, 2007a, Simola, 2014). The extent to which moral courage is cultivated and
exercised could strengthen moral judgment and action (Simola, 2014) thus alleviating moral
distress. Moral courage is essential to decreasing moral distress in the nursing profession
(Gallaher, 2011; Lachman, 2010; Murray, 2010). While ample studies have examined moral
distress in nurses (Elpern, Covert, & Kleinpell, 2005; Hamric & Blackhall, 2007; Lazzarin,
Biondi, & DiMauro, 2012; Sirilla, 2014), moral courage remains elusive. Within the field of
business ethics, moral courage is an important construct applicable to practices leading to ethical
action and specific types of ethical situations (Simola, 2014). Although a framework was
introduced for moral courage for nurses, (Lachman, 2010; LaSala & Bjarnason, 2010; Simola,
2014), it has not been tested and the relationships between moral distress and moral courage are
not clear. Qualitative studies for moral courage are scarce and a few anecdotal reports and case
studies have suggested strategies or activities to support moral courage, but such strategies have
not been tested (Lachman, 2007b; Lachman, 2010; LaSala, 2010; Murray, 2010). The literature
on moral distress has described nurses as strong patient advocates (Ferrell, 2006; Gutierrez,
2005). Whether or not nurses take action in specific moral challenges has not been quantifiable.
A few researchers investigated moral distress in oncology nurses, yet none of those
studies examined the relationship between moral distress and moral courage. The oncology
literature indicates that oncology nurses are observers of both the benefits and burdens of
chemotherapies (Ferrell, 2006; Hamric & Blackhall, 2007; Rice, Rady, Hamrick, Verheijde, &
Pendergast, 2008; Shepard, 2010) suggesting that the oncology nurse’s experience is an
emotionally and morally sensitive one with repeated exposure to moral challenges (Cohen &
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Erickson, 2006; LeBaron, Beck, Black, & Palat, 2014). Therefore, identifying which oncology
nurse characteristics are predictors of moral distress and moral courage can increase
understanding and provide context specific content to enhance the development of interventions
that lessen moral distress while supporting moral courage. Besides, understanding which nurse
actions exemplify morally courageous actions taken by these nurses can lead to methods to better
measure this phenomenon in the future. Because oncology nurses bear witness to suffering and
many moral conflicts (Cohen & Erickson, 2006), their experience provides them a chance to
bring an important voice in contributing to this body of research.
Statement of the Problem
Oncology nurses are fundamental to the care of those who have cancer. When oncology
nurses become morally distressed it is because they feel that their efforts to advocate for and
alleviate pain are not aligned with the patients’ treatment preferences or with treatments nurses
feel patients should be receiving. Nurses who reported frequent encounters of moral distress and
who are not able to resolve their distress may have moral distress residue. Nurses with repeated
exposure to distressing situations are likely to have higher moral distress, which can lead to
moral distress residue and to nurses leaving their current positions. Moral distress residue is the
cumulative effect occurring after a morally distressing clinical situation whereby the nurse’s
moral or ethical duty is compromised. Moral distress can lead to negative physical symptoms for
nurses and can alter the quality of care for patients, creating safety concerns as a result of
delayed care and decreased interactions with patients and their families. Ethical work
environments that nurture moral courage can potentially diminish these problems.
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Purpose of Study
The purpose of this study was twofold: (1) to investigate the relationship between moral
distress, moral distress residue, and moral courage in oncology nurses working in the adult
inpatient and outpatient settings, and (2) to identify oncology nurse predictors of moral distress
and moral courage, and specifically, oncology nurse actions that show moral courage. Data were
collected using the Moral Distress Scale-Revised (MDS-R) to measure moral distress and moral
residue, and the Professional Moral Courage Scale to measure moral courage. One open-ended
question was posed to obtain a more thorough understanding of the specific source of moral
distress and actions that demonstrate moral courage.
Research Questions
The major research questions asked in this study were:
1)

Is there a difference between oncology nurses in adult inpatient and outpatient settings
with respect to their moral distress and moral courage?

2)

Among oncology nurses, to what extent, if any, are moral distress and moral courage
related?

3)

What is the level of moral distress as reported by oncology nurses who report moral
distress residue described as having left a previous job, considered leaving a previous job
but stayed, or considering leaving a current job now?

4)

Which of the following nurse characteristics (education level, total number of years
working as registered nurse, total number of years working as oncology nurse, oncology
setting, oncology certification, ELNEC education, ethics education, and participation in
ethics consult) are significant predictors of Moral Distress in oncology nurses?
7

5)

Which of the following nurse characteristics (education level, total number of years
working as registered nurse, total number of years working as oncology nurse, oncology
setting, oncology certification, ELNEC education, ethics education, and participation in
ethics consults) are significant predictors of Professional Moral Courage in oncology
nurses?

6)

What actions are indicative of moral courage? Specifically, if you experienced a morally
challenging situation, describe how you took a stand for your patient; what influenced or
inhibited your action? What was the outcome of your stand? How did that make you
feel?
Significance of the Study
The qualitative and quantitative studies on moral distress have mainly focused on nurses

in the critical care setting (Browning, 2013; Gutierrez, 2005; Hamric & Blackhall, 2007;
Meltzer, & Huckabay, 2004; Mobley, Rady, Verheijde, Patel, & Larson, 2007; Wiegand & Funk,
2012). These studies showed that nurses experienced a variety of symptoms such as frustration,
anger, anxiety, and burnout, associated with providing medically futile treatments to patients that
did not improve outcomes at the patients’ end of life (Corley, Elswick, Gorman, & Clor, 2001;
Gutierrez, 2005; Meltzer, & Huckabay, 2004;Wiegand & Funk, 2012). Anecdotal reports
suggest that oncology nurses witness firsthand the conflicts arising from the delivery of
aggressive treatments to patients with terminal cancer and poor prognoses (Shepard, 2010).
Delivering aggressive interventions may generate moral distress for some nurses when they
perceive that their actions do not align with patient preferences or infringe upon an ethical duty
to prevent or minimize harm (Shepard, 2010). In general, ethical decision-making involves a
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hierarchy of principles whereby nurses are taught to support patient self-determination and a
duty to honor in any situation (ANA, 2015). Learning how oncology nurses internalize these
ethical principles to take a moral stand expands the current literature. Oncology nurses have
expressed challenges in 1) giving treatments that cause suffering, 2) being honest without taking
away hope, and 3) speaking out to prevent further distress (Pavlish, Brown-Saltzman, Jakel, &
Fine, 2014). Moral distress can arise when patients’ autonomy and decision making are
disregarded whereby the nurse’s core values include promoting, advocating for, and protecting
the health, safety and rights of the patient (ANA, 2015; Cohen & Erickson, 2006). The
compromised value could have unfavorable consequences that diminish the nurses’ moral
dimensions of caring and could prevent them from being full partners in healthcare (Hamric,
2012). Being a full partner in healthcare requires that the nurse recognize moral distress and act
courageously and professionally to address morally distressing clinical situations (Institute of
Medicine, 2011; Pendry, 2007).
Nurses are important human capital within healthcare organizations. A nurse’s
resignation emanating from moral distress and moral distress residue can have overwhelming
implications for patient safety and the quality of care. The implications can have a ripple effect
on patient satisfaction and the organization's mission and goals (American Association of
College of Nursing, 2012; Devillers & DeVon, 2012; Pendry, 2007). Consequently, a study that
examines the relationship between moral distress, moral distress residue, and moral courage in
oncology nurses, in adult inpatient and outpatient settings, adds to existing knowledge and
expands the science on moral distress and moral courage. This study also gives important
perspectives from oncology nurses on moral courage and underscores the importance of
supporting positive work environments, preserving nurse integrity, and improving nurse
9

retention in oncology nurses. This study was particularly important because a primary focus was
to understand the relationships between moral distress, moral distress residue, and moral
courage.
Organization of the Remainder of the Study
Chapter two contains the conceptual framework model, definitions, and synthesis of
relevant literature and identification of gaps in research on moral distress. Chapter three
describes the methodology and procedures used to gather data for the study. Chapter four
presents the study results and Chapter five contains the discussion of the study findings.
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CHAPTER TWO: REVIEW OF RELEVANT LITERATURE AND
FRAMEWORK

The chapter is divided into sections that include (a) the theoretical and conceptual
framework, (b) key definitions of variables (c) literature review of relevant research and
synthesis, (d) identification of gaps in the literature, and (e) summary.
Theoretical Framework and Conceptual Model
This study proposed an integrated conceptual framework (Figure 1) for investigating
moral distress, moral residue and moral courage in oncology nurses as moral agents. The basic
elements of the framework include moral challenges, nurse characteristics (i.e., age, education,
years of work experience, years of oncology nurse experience, work setting, ethics education,
end of life education, oncology certification), moral action of the nurse, moral courage, moral
distress, and moral residue (Corley, 2002; Elpern, Covert, & Kleinpell, 2005; Hamric, Borchers,
& Epstein, 2012; Lachman, Murray, Iseminger, & Ganske, 2012; Meltzer & Huckabay, 2004;
Mobley, Rady, Verheijde, Patel, & Larson, 2007; Pavlish, Brown-Saltzman, Jakel, & Fine,
2014). The oncology nurse as a moral agent is expected to incorporate professional and personal
values, drawing upon the nursing code of ethics, in the decision-making process to effectively
sort out what action should be taken (American Nurses Association, 2015; Hamric, 1999).
Moral challenges that stem from internal or external sources can act as the catalyst to generate
moral distress and moral courage (Corley, 2002; Hamric, Borchers, & Epstein, 2012; Sekerka,
Bagozzi, & Charnigo, 2009). The nurse as a moral agent must manage emotions, and balance
the desire to proceed with the moral action against competing threats or challenges (Sekerka,
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Bagozzi, & Charnigo, 2009). Nurses who manage emotions take the morally correct action and
demonstrate moral courage. Nurses who feel constrained or are unable to manage emotions and
take the moral action may demonstrate moral distress (Epstein, & Hamric, 2009). The frequency
and intensity of the moral challenge is associated with high levels of moral distress (Corley,
2002; Epstein, & Hamric, 2009). The cumulative or unresolved moral distress is indicative of
moral distress residue (Epstein, & Hamric, 2009; Hamric, Borchers, & Epstein, 2012).

Figure 1. Integrated model of moral distress, moral distress residue and moral courage.
The moral challenges specified in Figure 1 act as the stimuli to influence the moral action
of the nurse generating moral distress or moral courage. Repeated encounters with the stimuli
and unresolved or cumulative moral distress are associated with moral distress residue (Epstein,
& Hamric, 2009). Each of the constructs associated within the framework are discussed in the
literature review section.
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Definition of Key Variables
The following definitions will ensure uniformity and understanding of the terms used
throughout this study:
•

Moral action – relates to the “do” part of moral decision-making (Cox, 2008) with
respect to nurses’ obligation regarding principles of beneficence or doing good; nonmaleficence or doing no harm; justice or treating people fairly; reparations or making
amends for harm; fidelity and respect for all persons (Code of Ethics, ANA, 2015).

•

Moral agent - an individual or nurse with a duty to advocate for and to protect the rights
of the patient whereby, the nurse articulates nursing values and maintains the integrity of
the profession and its practice by striving toward moral action (American Nurses
Association, 2001).

•

Moral challenges – issues/concerns that stem from conflict between the patient, family
and healthcare team. The conflict can come from internal or external sources, which can
either inhibit or influence the nurse to take moral action leading to moral distress or
moral courage (American Association of Critical Care Nurses, 2006; Jameton, 1993).
Moral challenges have been identified as an antecedent of moral distress and moral
courage (Epstein & Hamric, 2009).

•

Moral distress – a perceived threat to one’s core values or identity that can inhibit the
individual from taking the right course of action (Corley, 2002; Epstein & Hamric, 2009;
Hamric, Borchers, & Epstein, 2012; Jameton, 1984).

13

•

Moral courage – the capacity to overcome fear and stand up for one’s core values and
willingness to speak out or take action in an assertive and principled manner (Lachman,
2007a).

•

Moral residue or moral distress residue – the result of repeated encounters and
unresolved or cumulative morally challenging situations associated with moral distress
(Corley, 2002) that can lead to nurse resignation or intention to leave as a result of
compromising one’s perceived moral obligation (Epstein & Hamric, 2009; Hamric, 2012;
Webster & Baylis, 2000).

•

Nurse characteristics – demographic variables measured in this study such as age, level
of education, years of work experience, years of oncology nurse experience, ethics
education, end-of-life education, and oncology certification.

•

Nurse resignation – a particular situation that causes the nurse to voluntarily leave the
job, not exclusive to moral distress but may be indicative of moral residue (Hamric,
Borchers, & Epstein, 2012; Mohr, Burgess, & Young, 2008).

•

Oncology nurse - a registered professional nurse or advanced practice nurse with
specialty education in the care of cancer patients (Oncology Nurses Society).
Literature Review
Moral distress is a serious concern affecting nurses and other healthcare professionals

(Allen, Judkins-Cohn, deVelasco, Forges, et al., 2013; Gutierrez, 2005; Hamric & Blackhall,
2007; Whitehead, Herbertson, Hamric, Epstein, & Fisher, 2015). Both qualitative and
quantitative studies have identified sources of moral distress and its potential physical and
emotional harms to nurses (Gutierrez, 2005; Ferrell, 2006; Meltzer & Huckabay, 2004; Sirilla,
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2014; Wiegand & Funk, 2012). For example, manifestations of moral distress included anger,
frustration, guilt, loss of self-worth, depression, nightmares, insomnia, suffering, resentment,
sorrow, anxiety, helplessness, powerlessness and burnout (Corley, 2002; Elpern, Covert, and
Kleinpell, 2005; Ferrell, 2006; Gutierrez, 2005; Meltzer & Huckabay, 2005; Wiegand & Funk,
2012). In an effort to examine the relationships between moral distress, ethical environment,
collaboration, and satisfaction with the quality of care, Hamric and Blackhall (2007) recruited a
convenience sample of nurses (n=196) and physicians (n=29) working in the critical care units
from two hospitals in the Southeastern United States. Moral distress patterns were similar for
both nurses and physicians. The most distressing situations involved feeling pressured to
continue aggressive treatment when such treatment was perceived to not be beneficial (Allen et
al., 2013; Hamric & Blackhall, 2007). Nurses often experience difficulties and feel ill-equipped
and powerless during interactions with these patients (Blomberg, Hylander & Tornkvist, 2008;
Epstein & Delgado, 2010). However, nurses perceived these situations as occurring more
frequently than did physicians (Allen et al., 2013; Hamric & Blackhall, 2007).
Moral challenges can come from a variety of situations that stem from conflict between
the patient, family, proxy decision makers, and healthcare team (Pavlish, Brown-Saltzman, Jakel,
& Fine, 2014). Nurses are likely to respond to situations that generate suffering and conflict with
patient goals and preferences, whereby the nurse either takes the moral action or is inhibited
from acting in a morally congruent manner. Particularly, moral challenges and perceived
powerlessness could undermine the nurses’ integrity in taking action or inhibit moral courage
(American Association of Critical Care Nurses, 2006; Jameton, 1993). Moral challenges have
been identified as precursors of moral distress (Epstein & Hamric, 2009) and moral courage
(Sekerka, Bagozzi, & Charnigo, 2009). The challenges are reinforced by internal and external
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influences. Internal influences include powerlessness, lack of assertiveness or ability to speak up
in a challenging situation, inability to identify moral concerns (Hamric, Borchers, & Epstein,
2012), and unsuccessful advocacy (Ferrell, 2006; Gutierrez, 2005). External sources include
poor communication patterns and collaboration by healthcare providers, providing false hope
(Hamric, & Blackhall, 2007; Pavlish, Brown-Saltzman, Jakel, & Fine, 2014) and treatments that
do not relieve pain or suffering (Ferrell, 2006: Gutierrez, 2005; LeBaron, Beck, Black, & Palat,
2014) or treatments perceived as medically inappropriate and not in the patient’s best interest,
following family preferences instead of patient’s wishes due to fear of litigation, and inadequate
administrative support (Hamric, Borchers, & Epstein, 2012). Repeated and unresolved
encounters of moral challenges are theorized to affect the frequency and intensity of moral
distress, resulting in a cumulative effect or moral residue (Epstein & Hamric, 2009). Evidence of
moral challenge includes disagreements about plans of care or disputes with policy, and disputes
about fair patient and staff treatment (Pavlish et al., 2014). Pavlish et al. (2014) utilized an
ethnographic approach to examine ethical conflicts in 30 nurses within the culture and setting of
oncology. Nurses described both internal and external sources as elements of poor
communication, with some providers not speaking up and others not willing to listen or consider
alternative perspectives (Pavlish et al., 2014). Moral challenges were perceived as delaying or
avoiding difficult conversations about poor prognoses or end-of-life care options, followed by
end-of-life situations that ignored the patient’s autonomy (Pavlish et al., 2014). As such, the
researchers concluded that physicians and nurses did not feel supported in discussing their
differences and missed opportunities to understand each other’s perspectives (Pavlish et al.,
2014). According to Gutierrez (2005), breaking bad news or discussing poor prognoses can be a
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catalyst for strengthening moral courage rather than creating missed opportunities between
patients, families, and healthcare providers.
Nurse as a Moral Agent and Nurse Characteristics
The nurse as a moral agent is derived from a fundamental belief that patients have a right
to self-determination and nurses have a duty to advocate for and to protect the rights of the
patient (American Nurses Association, 2015). The American Nurses Association (ANA) Code
of Ethics provides standards for the nursing practice to guide moral action (ANA, 2015). As a
moral agent, the nurse articulates nursing values and maintains the integrity of the profession and
its practice by striving toward moral action (ANA, 2015). Nurses assist patients with care
decisions about resuscitation status, withholding and withdrawing life-sustaining treatments,
advanced care planning; and facilitating informed decision-making, assisting patients to ask
questions and ensuring that the information is consistent with their values and preferences (ANA,
2015, pp. 6-8). Nurses must also bring forward difficult issues related to patient care and/or
institutional constraints upon ethical practice for discussion and review (ANA, 2015, p. 16).
Striving to take moral action requires that individuals address the moral challenge and be morally
responsible for what they have a moral duty or obligation to do (Lindh, da Silva, Berg, &
Severinsson, 2010; Sekerka, Bagozzi, & Charnigo 2009). Moral agents are expected to
incorporate professional and personal values, drawing upon multiple values in the moral
decision-making process and effectively sorting out and determining what action should be taken
while holding firm to previously held values (Sekerka et al., 2009). Moral agents are also aware
that their position, identity, and character may be at risk; however, they manage their emotions
and balance their desire to proceed with the action against other competing threats (Sekerka et
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al., 2009). Individuals who proceed with the moral action demonstrate a proactive approach to
workplace ethics to achieve solutions that serve and benefit the greater good (Sekerka et al.,
2009).
Moral distress results from not fulfilling one’s moral duties or obligations, or in fulfilling
them in a morally unacceptable way (Hare, 1981). Responses from a subset of nurses (n=20),
extracted and analyzed in a secondary analysis of qualitative data, suggest that nurses’ frustration
with their inability to provide appropriate pain and symptom relief for a patient may turn into
personal suffering leading to moral distress (Bernhofer & Sorrell, 2014). Nurses who knew what
to do but encountered barriers suffered the most, which may suggest that those with more
knowledge or education are at greater risk for moral distress if they cannot act on their
knowledge and skills (Bernhofer & Sorrell, 2014). In a different study, Browning (2013)
reported high moral distress intensity as the nurses’ age increased, however, nurses participating
in end-of-life nursing education (ELNEC) experienced significantly greater levels of moral
distress intensity and frequency, related to treatments not in the patient’s best interest or external
sources (Browning, 2013). This may be explained by nurses having gained more information
regarding the moral action to take in situations of delivering futile care to dying patients
(Browning, 2013). There are conflicting findings with respect to key nurse demographic
variables, and lacking from these studies are information pertaining to how nurses assimilate
ethics education and translate it into practice. A majority of studies suggest that referrals to the
ethics committees or establishing ethics rounds and moral communities may promote comfort
with ethics-related conversations and ease moral distress (Pavlish, Brown-Saltzman, Jakel, &
Fine, 2014; Rice, Rady, Hamrick, Verheijde, & Pendergast, 2008; Zuzelo, 2007). However,
findings from one study revealed that 75% (n=75) of the nurses had never initiated an ethics
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consultation related to a patient care dilemma, only 30% had completed a college level course in
biomedical ethics, 70% had not completed any undergraduate ethics courses and 85% had not
undertaken continuing education in ethics (Zuzelo, 2007). Some nurses had not received any
formal education in the area of ethics (Gutierrez, 2005). Assessing baseline information on how
ethics education is acquired and assimilated is essential to understand how this type of education
is translated in practice and utilized to improve ethical work environments.
Previous studies have found that years of experience in nursing were positively correlated
with Moral Distress scores (Elpern, Covert, & Kleinpell, 2005). However, another study
concluded that younger nurses (age 18 to 30 years old) scored significantly higher than the older
nurses; those with bachelor’s degree or higher had significantly higher distress scores compared
with associate’s degree nurses (Meltzer & Huckabay, 2004). Predictors of moral distress
intensity were greater after 34 years of age, after 3 years at current employment, and after 6 years
of nursing experience (Rice et al., 2008). In contrast, Mobley and colleagues (2007) found that
there were no significant associations between the moral distress intensity and age, critical care
experience, and total years in nursing practice. However, moral distress frequency related to
futile care (external sources) was significantly associated with nurses who were over 33 years of
age, had critical care experience greater than 4 years, and had a total of years in nursing practice
greater than 7 years (Mobley et al., 2007). In Sirilla’s (2014) study, there was a statistically
significant inverse relationship between education and Moral Distress scores. Nurses with
higher education had lower moral distress scores (Sirilla, 2014). Additionally, the only predictor
of Moral Distress scores was the type of nursing unit when age, education, years of nursing
experience, years of experience in oncology, and years with the current employer were included
in the model (Sirilla, 2014). At this time, findings on moral distress and oncology nurse
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characteristics are inconclusive. Consequently, further studies are needed to determine moral
distress in oncology nurses and the specific characteristics associated with moral residue and
moral courage.
Moral Distress and Moral Distress Residue
Moral distress residue is described as the cumulative effect that can remain long after a
morally distressing situation occurs whereby the nurse’s core values become compromised
(Webster & Bayliss, 2000). The frequency and intensity of a morally distressing situation is
associated with moral residue. The repeated encounters and unresolved distress have a
cumulative effect (Hamric, 2012). This phenomenon has been linked to emotional exhaustion, a
measure of burnout (Meltzer & Huckabay, 2004). Emotionally exhausted nurses can lose their
ability to be compassionate, leading to their resignation from their position (Corley et al., 2001;
Hamric & Blackhall, 2007) or leaving the profession entirely (Corley, 2002). Evidence suggests
that nurses with the highest levels (both frequency and intensity) of moral distress were likely to
have left a previous nursing job or considered leaving their jobs (Cavaliere, Daly, Dowling, &
Montgomery 2010; Corley, Elswick, Gorman, & Clor, 2001; Ferrell, 2006; Gutierrez, 2005;
Lazzarin, Biondi, & DiMauro, 2012; Maningo-Salinas, 2010; Sirilla, 2014).
Corley, Elswick, Gorman and Clor’s (2001) seminal research is most widely cited in
studies. Corley et al. (2001) developed and evaluated the original Moral Distress Scale (MDS)
to examine the effect of moral distress on previous decisions about resigning a nursing position.
Nearly 74% (n=158) of the nurses responded to the item about having left a previous job because
of moral distress, of which 15% (n=23) had actually left a previous job because of moral distress.
Nurses who had resigned from a previous job or who were contemplating leaving their jobs were
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associated with higher Moral Distress scores (Corley et al., 2001). In another study examining
moral distress in five separate healthcare provider groups, moral distress was statistically
significantly higher for healthcare professionals who had previously considered and actually left
a position compared with those who had not considered leaving (Allen, Judkins-Cohn, deVelasco
& Forges, 2013). Moral distress was also statistically significant for healthcare professionals
who were currently considering leaving a position compared with those who were not (Allen et
al., 2013). One large Italian study evaluating moral distress in pediatric oncology nurses (n=182)
reported that Moral Distress frequency scores were highest among respondents related to
following orders for pain medication even when the medication prescribed did not control the
pain, and providing care that did not relieve the child’s suffering because the physician feared
increasing the dose of pain medication would cause death (Lazzarin, Biondi, & DiMauro, 2012).
Of these respondents, 50.5% indicated that they had considered changing their jobs or work unit
and 13.7% had actually changed their unit or hospital due to moral distress (Lazzarin, Biondi, &
DiMauro, 2012). Although working with children with cancer is psychologically difficult, these
pediatric oncology nurses identified external sources (time constraints, medical power, policy,
and administration) as the main component or source of their moral challenge (Lazzarin, Biondi,
& DiMauro, 2012).
According to Epstein and Hamric (2009) morally distressed individuals behave morally
ineffective in part because their views have not been addressed, and their core values have been
compromised. Although not directly measured, Pavlish et al. (2014) deduced that during moral
conflict, the nurses’ emotions intensified and some conflicts were unresolvable. This reasoning
may support Epstein and Hamric’s (2009) claim that providers react more strongly to repeated
situations which, if unresolved, could erode moral thinking and manifest as moral residue. As
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moral distress and residue accumulate, providers could become emotionally exhausted (Hamric,
2012; Meltzer, & Huckabay, 2004). Moral distress residue has been difficult to quantify;
presumably it is a latent variable (Epstein & Hamric, 2009), and studies have not consistently
reported outcomes pertaining to this variable.
Moral Courage
Courage is described as an inner strength or quality that is fundamental to taking moral
action (Hawkins & Morse, 2014). Nurses who take a stand and act accordingly, regardless of the
perceived or actual threat when moral principles are threatened demonstrate moral courage
(Lachman, Murray, Iseminger, & Ganske, 2012). In general, moral courage is preceded by
challenges or threats (Hawkins & Morse, 2014). A threat to the patient may include pain and
suffering while challenges to the physician or nurse include delivering bad news to a patient or
family with a poor prognosis or confronting unethical practice (Hawkins & Morse, 2014). Moral
courage is also manifested in examples of patient advocacy in the face of fear and retribution
(Lachman, 2007a). Outcomes of courage include acting in the patient’s best interest by
alleviating pain or suffering, communicating with patients and family openly, and collaborating
with physicians effectively (Hawkins & Morse, 2014). The moral agent manages negative
emotions that may accompany the challenging situation, even risking personal character and
position (Sekerka, Bagozzi, & Charnigo, 2009). However, knowledge is lacking about nurses’
courageous actions in their practice. Although there are vast empirical studies on nurses’ moral
distress in practice, studies on moral courage in nursing have been limited in the literature.
The science regarding moral courage in nurses is mostly anecdotal, conveying the
experiences of others (Lachman, Murray, Iseminger, & Ganske 2012). But a handful of
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qualitative studies, mainly phenomenography or hermeneutic approaches on courage in nursing
appear in the literature (Gustafsson, Asp, & Fagerberg, 2009; Spence, 2004; Spence & Smythe,
2007). As such, courage was described as the capacity to overcome fear, stand up for one’s core
values and the willingness to speak out or take action in an assertive and principled manner
(Spence, 2004). Spence and Smythe (2007) explored moral courage in nurses (n=20) and
revealed that it was expressed in response to threats or challenges. The nurses reported that they
became cautious and sought support which afforded them the opportunity to uphold their
professional nursing standards and safeguard patients’ rights and safety (Spence & Smythe,
2007). Additionally, nurses (n=7) portrayed moral courage by questioning their own and others’
behavior and actions (Gustafsson et al., 2009) and as a result nurses with courage experienced
personal and professional growth (Ferrell, 2006). It has been suggested that features of nursing
action and moral courage include willingness to recognize and be sensitive to the suffering of
others, expression of empathy and compassion, helping those in need, doing something to
alleviate the suffering of others, and challenging the status quo (Lindh, da Silva, Berg, &
Severinsson, 2010).
Incidental findings of courage have been detected in moral distress literature. A common
barrier to taking moral action and resolving a moral conflict identified by 67% (n=8) of the
nurses was disagreement about patient care goals among the physician, the patient’s family and
the nurse (Gutierrez, 2005). These nurses were aware of their moral obligation but were
inhibited from discussing their moral differences. In this instance, the nurses may have lacked
the skills or moral courage to negotiate the moral conflict. Spence and Smythe (2007) described
moral courage relative to creating opportunities in a space between chance and security. Moral
distress was likely a struggle against limitations between chance and security that hindered good
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care. Little is known about what influences a nurse to respond to morally distressing situations
with moral courage. In one study by Ferrell (2006), participants were instructed to reflect on a
medically futile clinical experience or their experience with an ethical issue at end of life and to
describe how the experience personally affected them. An interesting response shared by 29%
(n=32) of the nurse participants was that they had become stronger advocates for respecting their
patients’ preferences (Ferrell, 2006). Courage is exhibited in advocacy when the nurse takes a
stand on behalf of the patient regardless of the consequence (Hawkins & Morse, 2014).
Researchers Wiegand and Funk (2012) used a descriptive approach to studying clinical
situations generating moral distress in critical care nurses. Data were collected using an openended survey to ascertain situations that caused moral distress in nurses and what the nurses
would do differently. The nurses also proposed future actions (Wiegand & Funk, 2012), but
whether or not those interventions have been effective and how nurses intervene in future action
after experiencing moral distress remains ambiguous. It is unclear whether nurses who do not
intervene have higher moral distress than those who do intervene. It is also unknown if those
who do intervene manifest moral courage and incorporate strategies to be more assertive on
moral issues.
Opportunities exist to develop interventions related to moral courage in nursing. To date,
quantitative studies on moral courage have been conducted in the business sector (Priesemuth,
2013) and military setting (Sekerka, Bagozzi & Charnigo, 2009). For example, Sekerka et al.
(2009) conducted a longitudinal study to develop ethics education, and create and test a scale to
measure professional moral courage in U.S. Naval officers. Critical incident interviews and
coding resulted in five themes and statements, which were tested in a different sample of officers
(Sekerka et al., 2009). The themes are moral agency, multiple values, endurance of threats,
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going beyond compliance, and moral goals. Findings from the study demonstrate that
individuals were predisposed toward moral behavior or taking moral action because they viewed
themselves as moral agents, and automatically took ownership of the challenge (Sekerka et al.,
2009).
The current study adds to the literature by investigating the relationship between moral
distress, moral distress residue and moral courage. Furthermore, understanding these
relationships is a key aspect to designing interventions and targeting resources where they are
needed most to alleviate moral distress and strengthen moral courage among nurses.
Gaps in Literature
Throughout the literature, there is evidence that moral distress is a serious concern
associated with certain clinical situations and some nurses experience moral distress residue and
leave their jobs. There have been intangible and incidental findings of moral courage in the
literature on moral distress. Opportunities exist to develop the empirical knowledge base of
moral courage and to explore nurses’ experiences with moral courage; for example, identifying
what characteristics promote or inhibit moral courage as well as which actions or activities
exemplify moral courage will expand the knowledge base (Lachman, Murray, Iseminger, &
Ganske, 2012). Accordingly, the current study expands research by providing a framework to
explore the relationship between moral distress, moral distress residue, and moral courage.
Furthermore, the current study examines the relationships between moral distress, moral distress
residue, and moral courage in oncology nurses in both the inpatient and outpatient settings.
Determining which nurse characteristics are predictors of moral distress and moral courage can
target strategies that alleviate moral distress, reduce nurse resignation, and build moral courage.
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Summary
As changes in health care become more complex, oncology nurses are at risk for moral
distress as they carry out routine care for patients with serious and terminal cancers. Studies on
moral distress have focused on nurses’ weakness and suffering rather than exemplifying their
strengths. One positive solution is to recognize that moral distress can be a catalyst for
strengthening moral courage, opening dialogue and self-reflection, and not just be a source of
suffering (Peter & Liaschenko, 2013). Little is known about the relationship between moral
distress, moral distress residue, and moral courage in oncology nurses. This study uses Hamric’s
revised 21-item Moral Distress in Healthcare Professionals Measurement Scale (MDS-R), and
Sekerka et al.’s 15-item Professional Moral Courage Scale to evaluate the relationships between
oncology nurse characteristics, moral distress, moral residue and moral courage. Furthermore, a
qualitative open-ended question regarding how courage is exemplified contributed to a
comprehensive understanding of the results. Moral courage is needed for moral action so that
nurses can carry out their moral obligations with integrity.
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CHAPTER THREE: METHODOLOGY

The purpose of this study was twofold: (1) examine the relationship between moral
distress, moral residue, and moral courage in oncology nurses working in the adult inpatient and
outpatient settings, and (2) identify which oncology nurse characteristics are predictors of moral
distress and moral courage and specifically, what oncology nurse actions illustrate moral
courage. The study employed a mixed method, non-experimental, correlational design and
qualitative content analysis to illuminate the quantitative data. The chapter discusses the
research methodology, study design, description of the population, data collection, sampling,
instrumentation, and procedures.
Research Questions
The research questions guiding this study were as follows:
1)

Is there a difference between oncology nurses in adult inpatient and outpatient settings
with respect to their moral distress and moral courage?

2)

Among oncology nurses, to what extent, if any, are moral distress and moral courage
related?

3)

What is the level of moral distress as reported by oncology nurses who report moral
distress residue described as having left a previous job, considered leaving a previous job
but stayed, or considering leaving a current job now?

4)

Which of the following nurse characteristics (education level, total number of years
working as registered nurse, total number of years working as oncology nurse, oncology
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setting, oncology certification, ELNEC education, ethics education, and participation in
ethics consult) are significant predictors of Moral Distress in oncology nurses?
5)

Which of the following nurse characteristic (education level, total number of years
working as registered nurse, total number of years working as oncology nurse, oncology
setting, oncology certification, ELNEC education, ethics education, and participation in
ethics consults) are significant predictors of Professional Moral Courage in oncology
nurses?

6)

What actions are indicative of moral courage? Specifically, if you experienced a morally
challenging situation, describe how you took a stand for your patient; what influenced or
inhibited your action? What was the outcome of your stand? How did that make you
feel?
Design
A mixed methods cross-sectional correlation design and qualitative content analysis was

used to investigate oncology nurses’ characteristics and the relationships between moral residue,
and scores on the Moral Distress and Moral Courage Scales. A parallel approach using one
open-ended qualitative statement, collected at the same time with the demographic and
quantitative data, was implemented to yield deeper explanations of findings from the quantitative
analysis (Creswell, Fetters, & Ivankova, 2004). In parallel combinations the methods are used
separately and the findings are integrated after the data are analyzed. This survey methodology
is practical and acceptable to participants because it is anonymous, and there is no manipulation
of intervention and no randomization of subjects is required (Polit & Beck, 2012). Internal
threats to validity such as selection bias and external threats related to whether relationships

28

observed hold true over variations in people and settings are limitations and there is no
possibility of exploring cause and effect (Polit & Beck, 2012).
Setting and Sample
Prior to conducting the study, approval from the University of Central Florida
Institutional Review Board (Appendix A) and the Oncology Nurses Society (Appendix B) were
obtained. A convenience sample of 274 nurses was drawn from a population of 2,423 oncology
nurses recruited from the membership roster of the Oncology Nursing Society (ONS) in the
Southeastern United States. ONS is a national association that has over 35,000 registered nurses
and other healthcare professionals (ONS, 2013). Oncology nurses who are members of ONS,
English reading, with work experience in the adult oncology inpatient or outpatient settings and
with one or more years of work experience, currently working full-time, or retired within six
months or less at time of the survey met the inclusion criteria. Licensed practical nurses (LPNs),
or nurses working part time, per diem, or in pediatrics were excluded from the study. A different
instrument is necessary for the pediatric oncology nurses; because of time and cost, it was not
feasible to include pediatric oncology nurses in the study. A power analysis determined a
minimum sample size of 159 was required to detect statistical significance. A response rate of
15-20% was expected based on similar studies (Beckstrand, Collette, Callister, & Luthy, 2012;
Radzvin, 2011). The sample was assumed to be representative of the population of oncology
nurses who are members of the professional organization.
Sampling
The software program G-Power 3.1.7 was used to calculate the minimum required sample
size, per statistical analysis (Faul, Erdfelder, Lang, & Buchner, 2007). Power analysis was
29

conducted for the research questions except question six. Research question six is an openended question intended to gather qualitative data for the study. When estimates from pilot data
or prior research is not available, a last resort is to use a small, medium or large conventions
(Polit, 2010), thus a medium effect size was feasible as an estimate in order to calculate the
number of subjects needed to avoid a Type II error (Polit, 2010; Sullivan & Feinn, 2012).
Cohen’s (1988) effect size guidelines were used to determine the effect sizes for the following
research questions. According to Cohen (1988), an effect size of .20 in a two-group mean
difference test is considered small, .50 is medium, and .80 is large. Research question one was
addressed with an independent-samples t test to compare differences in respondents’ mean scores
for Moral Distress working in inpatient and outpatient settings. Using a medium effect size d
=.50 a power of .80 and an alpha level of .05 for a two-tailed test, the calculated total sample size
of 128 (or 64 in each group) was required.
Research question two was addressed with a Pearson Correlation. As such, the sample’s
coefficient r is used to estimate the effect size. A correlation coefficient of .10 represents a weak
or small association; a correlation coefficient of .30 represents a moderate correlation; and a
correlation coefficient of .50 or larger represents a strong or large correlation (Polit, 2010, p.
202). Respondents’ scores for Moral Distress and Moral Courage were correlated to determine
what type of relationship, if any, occurred between the scores. Using a medium effect size = .30,
power of .80, and an alpha level of .05 for a two-tailed test, the calculated minimum sample size
of 85 participants was required for question two.
Research question three was addressed with ANOVA to compare the Moral Distress
mean scores of three groups. Cohen’s (1988) conventional values for small, medium, and large
effects correspond to values of eta-squared (η2) of .01, .06, and .14 respectively (Polit, 2010, p.
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159). Using an effect size η2 = .06 and alpha = .05, 53 participants per group was needed to
achieve a power of .80; or total sample size of 159 participants.
Research questions four and five were addressed with multiple regressions. A power
analysis is a precise way to determine sample size for multiple regression (Polit, 2010). Cohen’s
(1988) guidelines for effect size, referred to as f2 is a function of the value R2 and considered
small when R2 = .02, moderate when R2 = .13, and large when R2 = .30 (Polit, 2010, p. 242).
Given a moderate or medium effect size (f2 = .13), power of .80, eight predictors (at least eight
independent variables), and an alpha level of .05 for a two tailed test, the calculated minimum
sample size requirement of 109 participants was required for questions four and five. The power
analysis for research questions four and five assumed that each predictor was statistically
significantly related to the dependent variable, and thus, the regression model proposed, at most,
eight predictors. The researcher used the sample size requirement for the most stringent analysis
to set the minimum sample size for this study. In the event of missing data, oversampling was
done and all collected surveys were analyzed resulting in 187 subjects in the study.
Instrumentation
Moral Distress Scale-Revised (MDS-R)
The Moral Distress in Healthcare Professionals Measurement Scale (MDS-R) is a 21item, 0-4 point scale with two closed-ended variables. The scale measures an individual’s
perception to a situation based on two dimensions (frequency of the encountered situation and
the intensity of distress) and moral residue described as having left a previous job when moral
distress was not resolved (Appendix C). The scale represents the dependent variable and
measures both continuous and dichotomous data. All 21 items were scored by participants in
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terms of how often the situations arose, or frequency, and the level of disturbance on the scale, or
intensity (Hamric, Borchers, & Epstein, 2012). The scale for frequency ranges from 0 = never to
4 = very frequently, while intensity ranges from 0 = none to 4 = great. Composite scores were
calculated using SPSS. The scores for the 21 items have a range of 0 to 336 for a total score.
The scale contains a definition of moral distress and instructions for completing it. Respondents
could also write up to two statements specific to their practice environment in which they had
experienced moral distress and indicate the level of frequency and intensity. However, these
items are not calculated in the total score. Instead, descriptive statistics were used to discuss the
findings.
Content validity was evaluated by four experts familiar with the research on moral
distress by independent review of the 21 items, coding of primary and secondary sources of
moral distress in the revised items, and evaluating clarity and concision of the items for a
multidisciplinary provider (Hamric, Borchers & Epstein, 2012). This tool demonstrated good
internal consistency (Cronbach α = 0.89) and an 88% inter-rater agreement on both primary and
secondary sources of moral distress situations (Hamric et al, 2012). Full agreement was reached
for 19 of 21 items, resulting in one item being replaced and another item reworded substantially
(Hamric et al, 2012).
Hamric et al (2012) evaluated construct validity by testing hypothesis regarding the
relationships between moral distress and other variables identified in previous research. Each of
the three hypotheses was supported for the nurse population. Nurses with more experience in
their current positions demonstrated higher moral distress (r = .22, p = .005); moral distress was
negatively correlated with ethical climate (r= -.402, p < .001) and MDS-R scores were

32

significantly higher for those considering leaving their positions now (p < .001) (Hamric,
Borchers & Epstein, 2012).
Moral Distress Residue
The final section of the MDS-R scale contained two questions developed by the
researchers of the instrument (Hamric, Borchers, & Epstein, 2012). The first question evaluates
moral distress residue as described by respondents who had left a previous job or considered
quitting a previous job. The second question evaluates current levels of moral distress as
described by respondents considering quitting a current job now due to moral distress (Hamric,
Borchers, & Epstein, 2012). The two questions were:
1.

Have you ever left or considered quitting a clinical position because of your moral
distress with the way patient care was managed at your institution?

2.

a.

No, I’ve never considered quitting or left a position.

b.

Yes, I considered quitting but did not leave.

c.

Yes, I left a position.

Are you considering leaving your position now? Yes, No.
Responses to these questions captured the latent or proxy variable for moral residue

within the study. The developer found that higher moral distress scores were reported in nurses
who had left a previous position, followed by those who considered leaving a previous position
but stayed; nurses who never left or considered quitting had lower moral distress scores (Hamric,
Borchers, & Epstein, 2012).
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Professional Moral Courage Scale
Sekerka, Bagozzi and Charnigo (2009) Professional Moral Courage Scale (PMCS) is a
15-item, 7-point unipolar scale (Appendix D) that measures a respondent’s response from 1 =
never true to 7 = always true, with 4 = sometimes true as a midpoint. The PMCS has five themes
or dimensions which include 1) moral agency, 2) multiple values, 3) threat endurance, 4) beyond
compliance, and 5) moral goal. Moral agency pertains to qualities or characteristics of the moral
agent. Multiple values pertain to the application of personal and professional codes of conduct in
making decisions. Threat endurance pertains to taking the moral action in the face of challenges
or social pressures. Beyond compliance relates to striving to achieve the moral standard. Moral
goal is actualization or attainment of the moral standard. Each dimension contains three items.
The items measuring moral courage were obtained by two different researchers and derived from
analysis of the literature and qualitative analysis of critical incidents (Sekerka, Bagozzi, &
Charnigo, 2009).
Construct validity was examined by confirmatory factor analysis (CFA) (Sekerka,
Bagozzi, & Charnigo, 2009). The factor loadings were all high in value and statistically
significant. The true-score or trait variances for the five moral courage dimensions were
substantial except for one measure, the measure beyond compliance (Sekerka, Bagozzi, &
Charnigo, 2009). The trait variances ranged from 52% to 77%. The minimum standard is
acknowledged to be 50%; the measure of beyond compliance achieved a trait variance of 37%
(Sekerka, Bagozzi & Charnigo, 2009). The authors did not report a Cronbach alpha.
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Moral Courage Examined Qualitatively
The open-ended question ascertained how the nurse demonstrated moral courage
(specifically, if they experienced a morally challenging situation, how they took a stand for their
patient and what was the outcome of their stand? How did that make them feel?).
Demographic Data and Survey
The demographic data and survey contained 13 demographic variables and one additional
variable addressed through an open-ended question represented the independent variables
(Appendix E). The demographic data and pertinent open-ended question were derived from the
literature review and believed to be relevant to this study. The demographic data were
comprised of continuous and categorical data (age, gender, education level, total number of years
working as nurse, total number of years working as oncology nurse, work setting
(inpatient/outpatient, other), oncology certification, ELNEC education, ethics course
work/continuing education, participation in ethics consultation).
Procedures
Recruitment
The Principal Investigator (PI) sent a written proposal to ONS to obtain permission to
recruit member oncology nurses residing in two states within the Southeastern United States.
Prior to conducting the study, approval was obtained from the University of Central Florida
Institutional Review Board and the Oncology Nursing Society (ONS). The PI did not have direct
access to the membership email. The study was disseminated on February 27, 2015 by ONS
through email to 2,400 oncology nurse members in the targeted study population. An
abbreviated email (Appendix F) served as a cover letter announced the study and invited
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prospective participants to join the study. The abbreviated email described the study purpose,
value of the investigation, instructions for completing the survey, risks, benefits, and process to
ensure confidentiality, and who to contact for questions or assistance. Interested prospective
participants accessed the study using the embedded link to the Qualtrics ™ online survey.
Completion of the survey was deemed an informed consent. The total study time required was
15-20 minutes.
Data Collection
Qualtrics™, the online survey software, was used to generate the electronic demographic
data and survey, MDS-R which measures Moral Distress and Moral Residue, the Professional
Moral Courage Scale, and the open-ended question on Moral Courage for the data collection.
First, explanation of the study (describing the study purpose, what the participants would be
asked to do in the study, time required, risks/benefits, anonymity, and how to contact to principal
investigator) was provided to the participants. Next, participants completed the Demographic
Data Sheet which also contained 13 brief response items and one open-ended question on Moral
Courage, followed by the 21-item Moral Distress Scale-Revised (MDS-R), containing also the
Moral Residue items, and the 15-item Professional Moral Courage Scale. Enrollment lasted for
one month with one email reminder generated after week two. Data collection ended on March
31, 2015.
Confidentiality
The online survey was anonymous and no personal identifying information such as name
or special coding was used in the study data. Participation in the study was voluntary and
participants were given directions to contact the PI if they had any questions during the survey or
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after the survey was completed. There were no known risks, penalties or costs for participation
in the study. The returned surveys were kept in a password-protected computer. Only the PI and
research advisors had access to the online survey and study data. The study data will also be
shared with the developer of the MDS-R. The study results will be reported in the aggregate and
will be published.
Operationalizing Variables
Moral Distress Scale-Revised (MDS-R)
The Moral Distress Scale represents the dependent and independent variables, and items
on the scale contain continuous data.
Moral Distress Residue
Moral distress residue is a measure of nominal data and was coded, no = 0, and yes = 1.
Individuals reporting having left a position or considered leaving a position but stayed were
coded ‘1,’ reflecting the fact that they have experienced moral residue. Respondents reporting
never left were coded ‘0.’ Respondents who are currently considering leaving their positions
were coded ‘1’ to reflect current levels of moral distress. Respondents not leaving a current
position were coded ‘0’
Professional Moral Courage Scale and open-ended question
The moral courage scale represents the dependent variables, and items on the scale are
continuous data. The open-ended question was coded into themes using a preliminary set of
codes and the five sub themes from the Professional Moral Courage Scale.
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Demographic Data and Survey Questions
The demographic data and survey questions represent the independent variables. These
variables contain both continuous and categorical data. For example, age is continuous, level of
education was coded as 0 = BSN or lower and 1 = MSN or higher. To examine the categorical
data, dummy coding was used for dichotomous variables with two categories and effects coding
was applied to more than two categories (k-1 dummy variables for k categories).
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CHAPTER FOUR: RESULTS

Analysis of Data
The purpose of this study was to determine the relationship between moral distress, moral
residue, and moral courage; whether oncology nurse characteristics were predictors of moral
distress and moral courage; and specifically what actions were indicative of moral courage. A
convenience sample of oncology nurses, working in oncology adult inpatient and outpatient
settings were recruited for this study. The participants who were English-speaking, registered
nurses, working full time, or retired within six months or less met the inclusion criteria. A mixed
method, non-experimental, correlation design was used to answer the research questions. Data
were analyzed using the Statistical Package for the Social Science (SPSS) version 22.0 software
for Windows. Descriptive and inferential statistical analysis and findings of the qualitative
content analysis that describe the participants’ moral courage are presented in this chapter. First,
the preliminary data examination and descriptive statistics conducted on the data collected in this
study are presented. Next, results of the statistical analyses related to the research questions one
to five are presented. Last, the qualitative content analysis is presented for question six. Finally,
the links between qualitative and quantitative findings are explored.
Description of Sample
Quantitative data were entered into SPSS version 22 for Windows to perform data
examination and analysis. Of the 2,400 eligible oncology nurse participants, the raw data set
consisted of 274 respondents representing a response rate of 11.4%. A total of 76 (27.7)
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respondents had missing data of which 9.2% (n=7) accessed the study and dropped out without
completing the demographic information and study survey. Of the 76 respondents, 91% (n=69)
completed the demographic information, but did not complete the moral distress or professional
moral courage scales. Therefore, 76 cases were removed from the study leaving 198 for analyses.
The remainder of missing data for the MDS-R and PMCS scales were imputed wherever
possible. Specifically, for the MDS-R, missing frequency and intensity scores were imputed
using the sample mean (Mertler & Vannatta, 2010). Intensity scores could not be imputed for
seven respondents who did not provide any intensity scores, these respondents were removed
from the analysis leaving 191 subjects. For the PMCS, missing scores were imputed using the
sample mean. One respondent did not provide any PMCS scores, so this respondent was
removed from the study retaining 190 participants for analysis. The presence of outliers was
assessed using box plots. Outliers are values below Q1-1.5(Q3-Q1) or above Q3+1.5(Q3-Q1) or
equivalently, values below Q1-1.5 IQR or above Q3+1.5 IQR (Mertler & Vannatta, 2010). The
interquartile range was defined as the difference between the third quartile (Q3) and the first
quartile (Q1) (Mertler & Vannatta, 2010). The box plot in Figure 2 showed two outliers for the
MDS-R (high value of 224 and 264). These respondents did not provide a response to the openended question. The outliers were inspected and removed one at a time and Figures 3 shows box
plot after extreme outliers were removed for MDS-R. One outlier for the PMCS (low value of
3.93) was identified and removed (see Figures 4 and 5). After the removal of dropouts, missing
data, and outliers, a total of 187 participants were retained for this study and reported in the
findings.
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Figure 2. MDS-R with outlier

Figure 3. MDS-R after outliers removed
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Figure 4. PMCS with outlier

Figure 5. PMCS after outlier removed
The demographics for this sample are presented in Table 1. The participants had a mean
age of 52 years (SD = 10.3). The mean number of years of experience working as a nurse was
reported as 24 (SD = 11.7, Range = 3 - 50 years). The mean number of years working as an
oncology nurse was 17 (SD = 9.9, Range = 1 - 45 years), of which 59 (32%) had 1-10 years of
oncology work experience; 67 (36%) had 1-20 years of oncology work experience; 39 (21%) had
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21-30 years of oncology work experience; 18 (10%) had 31-40 years of oncology work
experience; and 2 (1%) had 41-45 years of oncology work experience. Thirty six percent of the
respondents (n=68) worked with inpatients, 61% (n=114) worked with outpatients, and 3% (n=5)
worked in ‘Other’ work setting, such as academic, research, and home health. Eighty-two
percent (n=154) of the respondents had specialty certification in oncology and 41% (n=77) had
attended an end of life and palliative care education provided by the End of Life Nursing
Education Consortium (ELNEC).
Descriptive Statistics of Demographic Variables
Table 1
Demographic Characteristics of the Sample N= 187
Variables

N (%)

Age
(M = 52, SD = 10.3)
Range
25-30
31-40
41-5051-60
61-70
71-80
Gender
Female
Male
Race/Ethnicity
White/Caucasian
African-American/Black
Asian
Hispanic/Latino
Other
Employment
Full time (36+ hours per week)
Part Time
Per Diem

8(4.0)
20 (11)
52 (20)
73 (39)
33 (18)
1(1.0)
180 (96)
7(4.0)
132 (76)
25 (13)
8(4.0)
4(2.0)
8(4.0)
157 (84)
12(6.0)
8(4.0)
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Variables
Retired, 3 months or less
Education (highest degree)
Diploma
Associate’s Degree
Bachelor’s Degree
Master’s Degree
DNP
PhD/DNSc
Current Work Setting
Inpatient Unit
Outpatient Clinic
Other
Oncology Nurse Certification
Yes
No
ELNEC Course
Yes
No
Basic Health Care Ethics
Ethics content integrated into program
Separate ethics course
No ethics content
Additional Courses or Ethics CEU
Yes
No
Participated in Ethics Consult
Yes
No
Moral Residue
Intent to quit current job now
position
Left
or considered leaving previous job /no intent to quit current job
Never considered quitting or left previous job/no intent to quit now

N (%)
6(3.0)
8(4.0)
43(23)
78(42)
45(24)
3(2.0)
9(5.0)
68(36)
114(61)
5 (3)
154(82)
33(18)
77(41)
110(59)
130(70)
39(21)
18(10)
112(80)
74(40)
49(26)
136(74)
31(17)
80(44)
73(39)

Reliability Analysis
Internal consistency for each of the composite variables and subscales was assessed with
Cronbach’s alpha reliability analysis. In this study, MDS-R reliability was supported with a
Cronbach α of .90. This finding was consistent with previous results (Allen et al, 2013; Hamric,
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Borchers, & Epstein, 2012; Whitehead et al, 2015). In this study, PMCS had a Cronbach α of
.93. Results of the reliability testing are presented in Table 2. Reliability values for all subscales
were acceptable.
Table 2
Cronbach’s Alpha Reliability Testing Results for Moral Distress Scale-Revised and Professional
Moral Courage Scale and Subscales
Scale
Moral Distress Scale-Revised (MDS-R)

α
.90

No. of items
21

Items
1-21

Professional Moral Courage Scale (PMCS)

.93

15

1-15

PMCS subscales
Moral Agency
Multiple Values
Endures Threat
Goes Beyond Compliance
Moral Goal

.84
.80
.84
.79
.81

3
3
3
3
3

1, 2, 3
4, 5, 6
7, 8, 9
10, 11, 12
13, 14, 15

Descriptive Statistics of Instrument (MDS-R and PMCS Scores)
Moral Distress Scale
Moral Distress Scale-Revised (MDS-R Score) is defined as the sum of the individual
frequency x intensity of all 21 responses in the MDS-R instrument. After imputation using the
sample mean, the MDS-R Score was summarized in Table 3. This score ranged from 13 to 201
points (higher scores indicate greater moral distress), with mean = 81.5 and standard deviation
=37.2. The skewness of MDS-R Score was 0.67 (Std Error = 0.18) indicating that the score was
skewed to the right. The kurtosis of MDS-R Score was 0.69 (Std Error = 0.35). The histogram is
presented in Figure 6.
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Table 3
Descriptive Statistics Moral Distress Scale-Revised (MDS-R)
N
Statistic

Range
Statistic

Minimum
Statistic

Maximum
Statistic

Mean
Statistic

Std. Dev
Statistic

187

188.0

13.00

201.00

81.5036

37.24784

MDS-R

Skewness
Statistic Std.
Error
.670 .178

Kurtosis
Statistic Std.
Error
.690 .354

Score

Figure 6. Histogram of the MDS-R Score further illustrates the skewness of the score
distribution.
The moral distress frequency x intensity (fxi) scores for each of the 21 items was also
calculated to obtain the fxi mean score for each item with a mean score ranging from low 1.20
(SD= 2.52) to high 6.10 (SD=4.72). For example items less distressing had low fxi mean scores,
such as: #15 Take no action about an observed ethical issue because the involved staff member
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or someone in a position of authority requested that I do nothing (M=1.20, SD=2.57); and #14
Increase the dose of sedatives/opiates for an unconscious patient that I believe could hasten the
patient’s death (M=1.31, SD=2.498). The most morally distressing event associated with the
highest mean score in this study was #2, Witness healthcare providers giving false hope to a
patient or family. The top three (by rank order) most morally distressing events differed by work
setting. For example nurses in the inpatient setting reported #3 Following the family’s wishes to
continue life support even though I believe it is not in the best interest of the patient, #2 witness
healthcare providers giving false hop to a patient or family, and #4 initiate extensive lifesaving
actions when I think they only prolong death. Nurses in the outpatient setting reported #2
Witness healthcare providers giving false hope to a patient or family, #18 witness diminished
patient care due to poor team communication, and #17 work with nurses or other healthcare
providers who are not as competent as patient care requires. Table 4 represents the total sample
21-item Moral Distress fxi mean scores and standard deviations in rank order.
Table 4
21-item Moral Distress Scale-R Frequency times Intensity Scores (fxi) Mean Scores and
Standard Deviations in Rank Order.

Moral Distress Item (fxi)

Mean

SD

2. Witness healthcare providers giving “false hope” to a patient or
family.

6.10

4.72

18. Witness diminished patient care quality due to poor team
communication.

5.72

3. Follow the family’s wishes to continue life support even though
I believe it is not in the best interest of the patient.

5.62

20. Watch patient care suffer because of a lack of provider
continuity.

5.58

4. Initiate extensive life-saving actions when I think they only
prolong death.

5.45

Rank
1

4.62
2
4.61
3
4.68
4
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4.59
5

Moral Distress Item (fxi)

Mean

SD

21. Work with levels of nurse or other care provider staffing that I
consider unsafe.

5.42

5.00

17. Work with nurses or other healthcare providers who are not as
competent as the patient care requires.

5.34

6. Carry out the physician’s orders for what I consider to be
unnecessary tests and treatments.

5.10

1. Provide less than optimal care due to pressures from
administrators or insurers to reduce costs.

4.72

5. Follow the family’s request not to discuss death with a dying
patient who asks about dying.

4.66

12. Provide care that does not relieve the patient’s suffering
because the physician fears that increasing the dose of pain
medication will cause death.

3.95

9. Assist a physician who, in my opinion, is providing incompetent
care.

2.73

16. Follow the family’s wishes for the patient’s care when I do not
agree with them, but do so because of fears of a lawsuit.

2.51

Rank
6

4.56
7
4.28
8
4.40
9
4.29
10
4.51
11

7. Continue to participate in care for a hopelessly ill person who is
being sustained on a ventilator, when no one will make a decision
to withdraw support.

3.54
12
3.70
13

2.49

3.90
14

19. Ignore situations in which patients have not been given
adequate information to insure informed consent.

2.37

13. Follow the physician’s request not to discuss the patient’s
prognosis with the patient or family.

2.29

3.67
15

10. Be required to care for patients I don’t feel qualified to care for.

16
2.26

3.10
17

1.71

8. Avoid taking action when I learn that a physician or nurse
colleague has made a medical error and does not report it.

3.62

3.06
18

11. Witness medical students perform painful procedures on
patients solely to increase their skill.

1.63

2.95
19

1.31

14. Increase the dose of sedatives/opiates for an unconscious
patient that I believe could hasten the patient’s death.

2.50
20

15. Take no action about an observed ethical issue because the
involved staff member or someone in a position of authority
requested that I do nothing.
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1.20

2.57
21

Professional Moral Courage Scale (PMCS)
The Professional Moral Courage Scale (PMCS) total score was defined by the average of
Moral Agency Score, Multiple Values Score, Endures Threat Score, Goes Beyond Compliance
Score, and Moral Goal Score. Each subscale score was defined by the average of the three items
within the category with a range of 1, ‘never true’ to 7, ‘always true’ with 4, ‘sometimes true’ as
a midpoint (Sekerka et al., 2009). In this study, PMCS subscale scores ranged from a low 2.67
to high 7.00 points, with mean scores varying from 5.8 (SD=1.04) to 6.37 (SD=0.63) indicating
an ability to respond to challenges with courage sometimes to nearly always true. For example,
Moral Agency was the highest (M=6.37, SD=0.63) indicating that on average nurses nearly
always had a predisposition toward the moral behavior and possessed a persistent willingness to
engage as a moral agent. The Multiple Value was the lowest score (M=5.8, SD =1.04)
suggesting that nurses felt less capable in their ability to draw on multiple value sets in moral
decision making and to effectively sort out and determine what needs to be exercised, and to
hold firm to beliefs despite external concerns or demands.
Table 5 shows the descriptive statistics of PMCS Score as well as its five subscales.
PMCS Score ranges from 4.47 to 7.00 points, with mean = 6.10 and standard deviation =0.60
(indicating sometimes to nearly always responding to challenges with courage). The skewness of
PMCS Score is –0.38 (Std Error = 0.18), which means the score is skewed to the left. The
kurtosis of PMCS Score is –0.58 (Std Error = 0.35).
Table 5
Descriptive Statistics for Professional Moral Courage Scale (PMCS) and Subscale

N

Range

Minimum

Maximum
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Mean

Std.
Dev

Skewness
Std.
Statistic Error

Kurtosis
Std.
Statistic Error

Moral Agency
Multiple Values
Endures Threat
Goes Beyond
Moral Goal
PMCS Total Score
Valid N (listwise)

187
187
187
187
187
187
187

2.67
4.33
4.00
2.67
4.00
2.53

4.33
2.67
3.00
4.33
3.00
4.47

7.00
7.00
7.00
7.00
7.00
7.00
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6.3658
5.7989
5.8944
6.1130
6.3297
6.1003

.62612
1.04236
.86653
.68798
.65033
.59524

-.885
-.999
-.526
-.383
-1.367
-.375

.178
.178
.178
.178
.178
.178

.193
.542
-.047
-.515
3.569
-.581

.354
.354
.354
.354
.354
.354

The chart below is the Histogram of the PMCS Score.

Figure 7. Histogram of PMCS scores shows a negative skewness of the distribution
Major Study Variables
A Pearson correlation coefficient was calculated for the relationships between the
dependent variables and independent variables. Age was positively correlated with total years
working as a registered nurse (YRSNRSG) (r = 0.759, p <0.01) and total years working as an
oncology nurse (YRSONC) (r = 0.533, p<0.01). YRSNRSG was positively correlated with
YRSONC (r = 0.630, p <0.01).
All five subscales of PMCS Score were positively correlated with each other and with
PMCS score itself at a significant level of 0.01 (p<0.01). Endures Threat was a weak positive
correlation with total years in nursing (YRSNURSG) (r = 0.207, p<0.01) indicating a significant
linear relationship between the two variables. Nurses with more years of nursing experience
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tended to respond with moral courage when facing an ethical or moral challenge, both perceived
threats and real danger with endurance. PMCS Score was a weak positive correlation with total
years of oncology experience (YRSONC) (r = 0.149, p<0.05). Nurses with more years of
oncology work experience tended to respond to moral challenges with moral courage. MDS-R
Score was not correlated with any of the listed variables in Table 6 at a 0.05 significance level.
Table 6
Correlation Matrix for Dependent Variables and Key Independent Variables
Variable
1
2
3
4
5
6
7
8
9 10
1.Age
2.YrsNursga
.759**
3.YrsOncb
.533** .630**
4.MoralAgencyc
.010
.011
.097
d
5.MoralValues
.107
.063
.111 .474**
6.EnduresThreate
.139 .207**
.125 .421** .351**
7.GoesBeyondf
.111
.082
.132 .550** .482**
.593**
8.MoralGoalg
.092
.109
.102 .546** .499**
.453**
.580**
9.PMCSh
.125
.127 .149* .745** .773**
.739**
.815** .774**
10.MDS-Ri
-.056
.017
.036
-.031
-.098
.032
-.091
-.011
-.055
Note: aTotal years nursing experience, bTotal years oncology experience, cMoral Agency, dMoral Values, eEndures
Threat, fGoes Beyond Compliance, gMoral Goal, hProfessional Moral Courage Scale, iMoral Distress Scale-Revised
*p< .05; **p < .01. (2-tailed)

Education level was divided into two groups, ‘BSN and below’ (EDUC_binary =0) and
‘Above BSN’ (EDUC_binary =1). The average of MDS-R score for ‘BSN and below’ is 83.71
(SD = 36.88), indicating higher moral distress and 7.21points higher than that of the ‘Above
BSN’. However, an independent samples t-test comparing the mean score of education level of
the two groups indicated that such a difference was not statistically significant (t (184) = 1.216, p
= 0.226). See the Tables 7 and 8.
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Table 7
MDS-R Mean Scores and Standard Deviations for Education Level.

MEAN (MDS-R)

EDUC_Binary
.00
1.00

N
129

Mean
83.7140

Std. Deviation
36.88034

Std. Error Mean
3.24713

57

76.5011

38.24256

5.06535

Table 8
Independent Samples T-test for MDS-R and Education Level
Levene’s Test
for Equality
of Variances

Education
MEAN (MDS-R)
Equal Variances
assumed
Equal variances not
assumed

F

Sig.

.644

.423

t-test for Equality of Means

t

df

Sig.
(2tailed)

Mean
Difference

Std. Error
Difference

95% Confidence
Interval of the
Difference
Lower

Upper

1.216

184

.226

7.21294

5.93247

-4.49146

18.91735

1.199

103.813

.233

7.21294

6.01678

-4.71881

19.14470

The average of PMCS score for ‘BSN and below’ was 6.09 (SD = 0.62), which was very
close to that of the ‘Above BSN’ as shown in Tables 9 and 10. The latter had a mean of 6.11
(SD = 0.55). The t-test indicated that there was no statistically significant difference of PMCS
score between the two Education groups (t (184) = - .287, p = 0.774).
Table 9
PMCS Mean Scores and Standard Deviations for Education Level
EDUC_Binary
MEAN (PMCS Score)

N

Mean

Std. Deviation

Std. Error Mean

.00

129

6.0911

.61855

.05446

1.00

57

6.1184

.54889

.07270
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Table 10
Independent Samples T-test for PMCS and Education level
Levene’s Test
for Equality
of Variances

Education
MEAN (PMCS Score)
Equal Variances
assumed
Equal variances not
assumed

F

Sig.

1.527

.218

t-test for Equality of Means

t

df

Sig.
(2tailed)

Mean
Difference

Std. Error
Difference

95% Confidence
Interval of the
Difference
Lower

Upper

-.287

184

.774

-.02734

.09514

-.21505

.16037

-.301

119.955

.764

-.02734

.09084

-.20720

.15251

The average of MDS-R score for the nurses with certification in oncology (ONCCERT
=1) was 83.12 (SD = 37.11), indicating more moral distress or about 10 points higher than the
nurses without certification in oncology (M = 73.94, SD = 37.51). The t-test indicated that there
was no statistically significant difference of MDS-R score between the two groups (t (185) = 1.288, p = 0.199). See Tables 11 and 12.
Table 11
MDS-R Mean Scores and Standard Deviations for Oncology Certification
ONCCERT
MEAN

(MDS-R)

N

Mean

Std. Deviation

Std. Error Mean

0

33

73.9400

37.51029

6.52970

1

154

83.1244

37.11312

2.99066

54

Table 12
Independent Samples T-test for MDS-R and Oncology Certification
Levene’s
Test for
Equality of
Variances

ONCCERT

MEAN (MDS-R)
Equal Variances
assumed
Equal variances not
assumed

t-test for Equality of Means

df

Sig.
(2tailed)

Mean
Difference

Std. Error
Difference

F

Sig.

t

.538

.464

-1.288

185

.199

-9.18431

-1.279

46.406

.207

-9.18431

95% Confidence
Interval of the
Difference
Lower

Upper

7.13243

-23.25567

4.88705

7.18200

-23.63750

5.26888

The average of PMCS score for the nurses with certification in oncology (ONCCERT =1)
was 6.11 (SD =0.58), about 0.06 points higher than the nurses without certification in oncology
(M = 6.05, SD = 0.66). The t-test indicated that there was no statistically significant difference
of PMCS score between the two groups (t (185) = -.557, p = 0.578) as shown in Tables 13 and
14.
Table 13
PMCS Mean Scores and Standard Deviations for Oncology Certification
ONCCERT
MEAN (PMCS Score)

N

Mean

Std. Deviation

Std. Error Mean

0

33

6.0478

.65849

.11463

1

154

6.1116

.58251

.04694
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Table 14
Independent Samples T-test for PMCS and Oncology Certification
Levene’s Test
for Equality
of Variances

ONCCERT
MEAN (PMCS Score)
Equal Variances
assumed
Equal variances not
assumed

t-test for Equality of Means

Sig.
(2tailed)

F

Sig.

t

df

.996

.320

-.557

185

-.515

43.377

.609

95% Confidence
Interval of the
Difference

Mean
Difference

Std. Error
Difference

-.06376

.11439

-.28944

.16192

-.06376

.12387

-.31350

.18598

Lower

Upper

The average MDS-R score for the oncology nurses who work in an inpatient work setting
(Inpatient_binary=1) is 90.96 (SD = 39.62) or 14 points higher than nurses in an outpatient work
setting (Inpatient_binary=0). The latter had an average MDS-R score of 77.04 (SD = 34.88).
The t-test indicated a statistically significant difference of MDS-R score between the two groups
(t (180) = -2.475, p = 0.014). See Tables 15 and 16.
Table 15
MDS-R Mean Scores and Standard Deviations for Inpatient and Outpatient Worksetting
Inpatient_binary
MEAN (MDS-R )

N

Mean

Std. Deviation

Std. Error
Mean

.00

114

77.0404

34.88312

3.26710

1.00

68

90.9641

39.61644

4.80420
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Table 16
Independent Samples T-test for MDS-R and Inpatient/Outpatient Work setting
Levene’s
Test for
Equality of
Variances

Inpatient/Outpatient

t-test for Equality of Means

F

Sig.

t

1.039

.309

-2.475
-2.397

Sig. (2tailed)

Mean
Difference

Std. Error
Difference

180

.014

-13.92375

127.174

.018

-13.92375

df

95% Confidence
Interval of the
Difference
Lower

Upper

5.62585

-25.02484

.-2.82265

5.80984

-25.42023

-2.42726

MEAN (MDS-R)
Equal Variances assumed
Equal variances not
assumed

The average of PMCS score for the nurses with inpatient work setting
(Inpatient_binary=1) was 6.08 (SD = 0.63), about 0.03 points lower than the nurses in outpatient
or other work settings in oncology (Inpatient_binary=0). The latter had an average PMCS score
of 6.11 (SD = 0.57). The t-test indicated that there was no statistically significant difference of
PMCS score between the two groups (t (180) = .333, p = 0.740). See Tables 17 and 18.
Table 17
PMCS Mean Scores and Standard Deviations for Inpatient and Outpatient Work setting
Inpatient_binary
MEAN (PMCS )

N

Mean

Std. Deviation

Std. Error
Mean

.00

114

6.1093

.57433

.05379

1.00

68

6.0790

.62904

.07628

57

Table 18
Independent Samples T-test for PMCS and Inpatient/Outpatient Work setting
Levene’s Test
for Equality
of Variances

Inpatient/Outpatient
MEAN (PMCS)
Equal Variances
assumed
Equal variances not
assumed

F

Sig.

.693

.406

t-test for Equality of Means

t

df

Sig.
(2tailed)

Mean
Difference

Std. Error
Difference

95% Confidence
Interval of the
Difference
Lower

Upper

.333

180

.740

.03033

.09121

-.14965

.21031

.325

130.994

.746

.03033

.09334

-.15432

.21498

The average of MDS-R score for nurses with End-of-Life Nursing Education Consortium
(ELNEC) course (ELNEC = 1) was 84.3 (SD = 38.90) or 4.77 points higher than nurses with no
ELNEC course (ELNEC = 0). Those with no ELNEC course had an average MDS-R score of
79.54 (SD = 36.09) as shown in Table 19. The t-test indicated that there was no statistically
significant differences between the two groups (t(185) = -.862, p = 0.390). See Table 20.
Table 19
MDS-R Mean Scores and Standard Deviations for End of Life Nursing Education (ELNEC)
ELNEC
MEAN (MDS-R )

N

Mean

Std. Deviation

Std. Error
Mean

0

110

79.5371

36.09546

3.44157

1

77

84.3129

38.90094

4.43317
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Table 20
Independent Samples T-test for MDS-R and End of Life Nursing Education (ELNEC)
Levene’s
Test for
Equality of
Variances

ELNEC
MEAN (MDS-R)
Equal Variances
assumed
Equal variances not
assumed

t-test for Equality of Means

df

Sig.
(2tailed)

Mean
Difference

Std. Error
Difference

F

Sig.

t

.103

.748

-.862

185

.390

-4.77582

-.851

155.764

.396

-4.77582

95% Confidence
Interval of the
Difference
Lower

Upper

5.53834

-15.70225

6.15061

5.61226

-15.86177

6.31013

The average of PMCS score for nurses with ELNEC course (ELNEC = 1) was 6.13 (SD
= 0.60) or 0.05 points higher than nurses with no ELNEC course (ELNEC = 0). Those with no
ELNEC course had an average PMCS score of 6.08 (SD = 0.59). The t-test indicated that there
was no statistically significant differences between the two groups (t(185) = -.538, p = 0.591. See
Tables 21 and 22.
Table 21
PMCS Mean Scores and Standard Deviations for End of Life Nursing Education (ELNEC)
ELNEC
MEAN (PMCS)

N

Mean

Std. Deviation

Std. Error
Mean

0

110

6.0807

.59161

.05641

1

77

6.1284

.60316

.06874
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Table 22
Independent Samples T-test for PMCS and End of Life Nursing Education
Levene’s
Test for
Equality of
Variances

ELNEC
MEAN (PMCS)
Equal Variances
assumed
Equal variances not
assumed

t-test for Equality of Means

df

Sig.
(2tailed)

Mean
Difference

Std. Error
Difference

F

Sig.

t

.120

.730

-.538

185

.591

-.04769

-.536

161.700

.592

-.04769

95% Confidence
Interval of the
Difference
Lower

Upper

.08861

-.22251

.12714

.08892

-.22328

.12791

The average MDS-R score for the group of nurses who had integrated Basic Ethics
Education into their nursing program was 79.07 (SD=35.71). The average MDS-R score for the
group of nurses who had a Separate Ethics Course was 93.40 (SD=36.73), which was the highest
group. The average MDS-R score for the group of nurses who had No Ethics content in their
nursing program was 73.33 (SD=45.35). See Table 23.
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Table 23
MDS-R Mean Scores and Standard Deviations for Basic Ethics Education

N
1-integrated
2- separate
3- none
Total

130
39
18
187

Mean
79.0664
93.3983
73.3341
81.5036

Std.
Deviation
35.70897
36.72742
45.25434
37.24784

Std. Error
3.13188
5.88109
10.66655
2.72383

95% Confidence
Interval for Mean
Lower
Upper
Bound
Bound
72.8698
85.2629
81.4926 105.3039
50.8297
95.8386
76.1300
86.8772

Minimum
14.00
13.00
16.00
13.00

Maximum
185.00
201.00
197.00
201.00

The ANOVA test results indicate that there was no significant difference of the MDS-R
score among the nurses with different Basic Ethics Education background (F (2,184) = 2.75, p =
.067). The ANOVA results are displayed in Table 24.
Table 24
ANOVA for MDS-R Scores and Basic Ethics Education
MDS-R
Between Groups
Within Groups
Total

Sum of Squares
7491.386
250565.362
258056.748

df
2
184
186

Mean Square
3745.693
1361.768

F

Sig.
2.751

.067

The ANOVA test results indicated that there was no significant difference of the PMCS
score among the nurses with different Basic Ethics Education background (F (2,184) = 0.252, p
= 0.777) as displayed in Tables 25 and 26.
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Table 25
PMCS Mean Scores and Standard Deviations for Basic Ethics Education

PMCS
1-integrated
2- separate
3- none
Total

N
130
39
18
187

Mean
6.0826
6.1601
6.0988
6.1003

Std.
Deviation
.62496
.56919
.42190
.59524

Std. Error
.05481
.09114
.09944
.04353

95% Confidence
Interval for Mean
Lower
Upper
Bound
Bound
5.9742 6.1911
5.9756 6.3447
5.8890 6.3086
6.0145 6.1862

Minimum
4.47
4.67
5.29
4.47

Maximum
7.00
7.00
6.67
7.00

F

Sig.

Table 26
ANOVA for PMCS and Basic Ethics Education

PMCS
Between Groups
Within Groups
Total

Sum of Squares
.180
65.721
65.902

df

Mean Square
.090
.357

2
184
186

.252

.777

An independent t-test was calculated comparing the mean score for MDS-R and PMCS
of participants who identified themselves as taking continuing ethics education (ETHICSCEU =
1) to the mean score of participants who did not take continuing ethics education (ETHICSCEU
= 0). The results indicated that there was no impact on MDS-R and PMCS scores and whether
the participants had taken continuing education courses in bioethics or not. The results are
shown below in Tables 27, 28, 29, and 30.
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Table 27
MDS-R Mean Scores and Standard Deviations for Ethics Continuing Education Units (CEU)

ETHICCEU
MEAN (MDS-R)

N

Mean

Std. Deviation

Std. Error
Mean

0

74

81.9603

39.39340

4.57939

1

112

81.2018

36.11129

3.41220

Table 28
Independent Samples T-test for MDS-R Scores and Ethics Continuing Education Units (CEU)
Levene’s Test
for Equality of
Variances

ETHICCEU
MEAN (MDS-R)
Equal Variances
assumed
Equal variances not
assumed

F
1.526

t-test for Equality of Means

Sig.

t

.218

.135
.133

Sig. (2tailed)

Mean
Difference

Std. Error
Difference

184

.893

.75851

146.802

.895

.75851

df

95% Confidence
Interval of the
Difference
Lower

Upper

5.60995

-10.30958

11.82660

5.71086

-10.52760

12.04462

Table 29
PMCS Mean Scores and Standard Deviations for Ethics Continuing Education Units (CEU)

ETHICCEU
MEAN (PMCS)

N

Mean

Std. Deviation

Std. Error
Mean

0

74

6.0189

.57581

.06694

1

112

6.1515

.60645

.05730
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Table 30
Independent Samples T-test for PMCS Score and Ethics Continuing Education Units (CEU)
Levene’s Test
for Equality of
Variances

ETHICCEU
MEAN (PMCS)
Equal Variances
assumed
Equal variances
not assumed

F
1.069

t-test for Equality of Means

df

Sig.
(2tailed)

Mean
Difference

Std. Error
Difference

95% Confidence
Interval of the
Difference

Sig.

t

Lower

Upper

.303

-1.489

184

.138

-.13263

.08906

-.30834

.04308

-1.505

161.992

.134

-.13263

.08812

-.30663

.04137

An independent samples t-test was calculated comparing the mean score of participants
who requested or took part in an ethics consult (ETHICSCON=1) to the mean score of
participants who did not request or participate in an ethics consult (ETHICSCON =0). The
results indicated that there was no impact on MDS-R (Tables 31 and 32) and PMCS scores
(Tables 33 and 34) and whether the participants requested or participated in ethics consult or not
(t(183) = -1.239, p = .217) and (t(183) = -.723, p = .471) respectively.
Table 31
MDS-R Mean Score and Standard Deviation for Participated or Requested Ethics Consult
ETHICSCON
MEAN (MDS-R)

N

Mean

Std. Deviation

Std. Error
Mean

0

136

79.1663

37.37156

3.20459

1

49

86.8379

36.56674

5.22382
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Table 32
Independent Samples T-test for MDS-R Score and Ethics Consult
Levene’s Test
for Equality
of Variances

ETHICSCON
MEAN (MDS-R)
Equal Variances
assumed
Equal variances not
assumed

t-test for Equality of Means

df

Sig.
(2tailed)

Mean
Difference

Std. Error
Difference

F

Sig.

t

1.275

.260

-1.239

183

.217

-7.67165

-1.252

86.566

.214

-7.67165

95% Confidence
Interval of the
Difference
Lower

Upper

6.19183

-19.88821

4.54491

6.12843

-19.85343

4.51013

Table 33
PMCS Mean Scores and Standard Deviations for Participated or Requested Ethics Consult
ETHICSCON
MEAN (PMCS)

N

Mean

Std. Deviation

Std. Error
Mean

0

136

6.0820

.60725

.05207

1

49

6.1541

.57399

.08200

Table 34
Independent Samples T-test for PMCS Score and Ethics Consult
Levene’s Test
for Equality
of Variances

ETHICSCON
MEAN (PMCS)
Equal Variances
assumed
Equal variances
not assumed

t-test for Equality of Means

df

Sig.
(2tailed)

Mean
Difference

Std. Error
Difference

95% Confidence Interval
of the Difference

F

Sig.

t

.190

.663

-.723

183

.471

-.07210

.09975

-.26892

.12472

-.742

89.353

.460

-.07210

.09714

-.26509

.12089
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Lower

Upper

Quantitative Analysis for Main Research Questions
The five quantitative research questions (RQ) posited for this study and analyses are
discussed below.
RQ1
Is there a difference between oncology nurses in adult inpatient and outpatient settings
with respect to their moral distress and moral courage?
To address research question one, independent sample t- tests were conducted for MDSR scores and PMCS scores relative to inpatient (inpatient_binary = 1) and outpatient
(inpatient_binary = 0) settings. The results indicate that oncology nurses working in adult
inpatient setting had significantly higher Moral Distress than oncology nurses in outpatient
setting. These results were presented previously in Table 15 and Table 16.
RQ2
Among oncology nurses, to what extent, if any, are moral distress and moral courage
related?
Research question two was assessed using correlation analysis. A Pearson correlation
matrix was obtained to examine the relationships between Moral Distress Scores, Professional
Moral Courage Scores, and Professional Moral Courage Subscales. The correlation matrix was
presented already in Table 5. No significant correlation was found between the Moral Distress
score and Professional Moral Courage Score and PMCS Subscales. The Pearson’s correlation
between MDS-R score and PMCS score was r = – 0.06, (p = 0.45). The Pearson’s correlations
between MDS-R score and PMCS subscales are all weak and not statistically significant (-0.1
<r<0.1 and p>0.05).

66

A Pearson’s correlation was calculated by inpatient setting examining the relationship
between participants’ MDS-R scores and PMCS scores. A weak correlation that was not
significant was found (r = .129, p =.386). A Pearson’s correlation was calculated by outpatient
setting examining the relationship between participants’ MDS-R scores and PMCS score. A
weak correlation that was not significant was found (r = -.165, p = .147). There is no
relationship between levels of Moral Distress and scores on the Professional Moral Courage
Scale regardless of work settings. Even though not significant, the MDS-R scores for inpatient
group were positively correlated and the outpatient group was negatively correlated.
RQ3
What is the level of moral distress as reported by oncology nurses who report moral
distress residue described as having left a previous job, considered leaving a previous job but
stayed, or considering leaving a current job now?
To address this question, first, the participants were split into three groups as shown
below in Table 35 based on their responses to the following two survey questions:
1. Have you ever left or considered quitting a clinical position because of your moral
distress with the way patient care was handled?
2. Are you considering leaving your position now?
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Table 35
Description of the Three Groups for Moral Distress Residue
CURRENTQUIT = 1

CURRENTQUIT = 0

QUITCONSID = 1

Participants who left a previous job
Participants who considered leaving previous
job but stayed
No intent to quit current job now
(Group 2)
Participants who never considered leaving or
left a previous job
No intent to quit current job now
(Group 3)

Intent to quit current job now
(Group 1)
QUITCONSID = 0

The average MDS-R scores for Group 1 was 94.28 (SD=38.88), Group 2 was 85.26 (SD40.03), Group 3 was s 72.11 (SD 31.93) as shown in Table 36. Group 1 had the highest average
MDS-R score (M=94.28, SD=38.88) suggesting that both previous levels and repeated
encounters of moral distress are associated with moral distress residue.
Table 36
Descriptive Statistics of MDS-R by Group Defined in Table 35

MEAN (MDSR)
1-intent to quit
2- left/consider
3- never left
Total

N

Mean

31
80
73
184

94.2750
85.2570
72.1107
81.5607

Std.
Deviation
38.88221
40.02761
31.92724
37.54384

Std. Error
6.98345
4.47522
3.73680
2.76777

95% Confidence
Interval for Mean
Lower
Upper
Bound
Bound
80.0129 108.5371
76.3493
94.1647
64.6615
79.5598
76.0998
87.0215

Minimum
14.00
13.00
14.00
13.00

Maximum
185.00
201.00
163.00
201.00

The ANOVA test showed that there was a significant difference of the mean MDS-R
scores among the three different groups (F (2,181) = 4.66, p = 0.011) as shown in Table 37.
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Table 37
ANOVA Results for Comparing MDS-R among the Three Groups

MEAN (MDS-R)
Between Groups
Within Groups
Total

Sum of Squares
12623.400
245322.424
257945.823

df
2
181
183

Mean Square
6311.700
1355.373

F
4.657

Sig.
.011

The analyses indicate a statistically significant difference between the moral distress
levels among the three groups of oncology nurses. The oncology nurses in group one who had
intent to quit their current job had the highest level of moral distress (94 points), about 9 points
higher than those in group two who had either left a previous job or those that considered leaving
a previous job but stayed (85 points). Those who left and considered leaving a previous job but
stayed scored 13 points higher than group three who neither considered quitting nor left a
previous job and had no intent to quit a current job now (72 points).
RQ4a
Which nurse characteristics are significant predictors of moral distress in oncology
nurses?
To examine the categorical predictors in research questions 4 and 5, dummy coding was
used for dichotomous variables with two categories and effects coding was applied to more than
two categories (k-1 dummy variables for k categories). A stepwise multiple linear regression
was conducted to determine whether the following characteristics (education level, total number
of years working as registered nurse, total number of years working as oncology nurse, oncology
setting, oncology certification, ELNEC education, ethics education, and participation in ethics
consult) were predictors of moral distress score. Total number of years in nursing (Yrsnursg)
and total number of years working in oncology (Yrsonc) were treated as continuous variables.
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All other variables were treated as categorical variables. Multiple regression approach was
identified as an appropriate tool to analyze the data gathered for this research question. Multiple
regression methods were used to explore the best fits. In the stepwise regression, the
significance level for variable entry is set to be 0.05; the significance level for variable removal
is set to be 0.10. (An entry level significance level was also set at 0.10 with a removal
significance level at 0.15, however no additional predictors were found). All of the relevant
independent variables were set as inputs for the auto selection and removal. The regression was
first conducted on the original MDS-R score without any transformation.
The researcher then conducted the regression on the natural logarithm of the MDS-R
scores (LOGNMDS). Both regression results yielded the same conclusion that the oncology
setting (Inpatient or Outpatient) was a significant predictor of the Moral Distress Score in
oncology nurses. The Inpatient group had a significantly higher moral distress level than the
Outpatient group. The results are presented in Tables 38 and 39.
Table 38
Stepwise Multiple Regression on MDS-R (without Transformation)

Model
1

(Constant)
Inpatient_binary

Unstandardized
Coefficients
B
Std. Error
74.521
4.600
18.689
7.530

Standardized
Coefficients
Beta
.210

Dependent Variable: MDS-R
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t
16.201
2.482

Sig.
.000
.014

Table 39
Stepwise Multiple Regression on LOGNMDS (transformed MDS-R)

Model
1

(Constant)
Inpatient_binary

Unstandardized
Coefficients
B
Std. Error
4.133
.066
.274
.108

Standardized
Coefficients
Beta

t
62.840
2.549

.215

Sig.
.000
.012

Dependent Variable: LogNMDS
Though the difference of the moral distress level between the Inpatient and Outpatient
groups was statistically significant (F(1,134) = 6.161, p = .014), with an R2 of .044. The small
R2 values (0.044 for original MDS-R in Table 40, and 0.046 for the transformed LogNMDS in
Table 41) yielded from the regression models indicated that only a trivial percentage of the moral
distress score variance could be accounted for by the nurse’s oncology setting. This suggests
that other variables could have been significant but data were not collected.
Table 40
Regression Model Summary with the Original MDS-R (without Transformation)
Change Statistics
Model
1

R
.210a

R Square
.044

Adjusted R
Square
.037

Std. Error of
the Estimate
42.43964

R Square
Change
.044

F Change
6.161

df1
1

df2
134

Sig. F
Change
.014

df2
134

Sig. F
Change
.012

a. Predictors: (Constant), Inpatient_binary

Table 41
Regression Model Summary with Transformed MDS-R (LogNMDS)
Change Statistics
Model
1

R
.215a

R Square
.046

Adjusted R
Square
.039

Std. Error of
the Estimate
.60687

a. Predictors: (Constant), Inpatient_binary
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R Square
Change
.046

F Change
6.499

df1
1

Normality was assessed through examination of the histogram. The histogram in Figure 8
shows that the unstandardized residuals are asymmetrical and somewhat skewed to the left
(negatively skewed distribution).

Figure 8. Histogram unstandardized residuals LogNMDS
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The assumption of linearity was assessed by examining the residual scatterplot. The
scatterplot in Figure 9 show the points are somewhat evenly distributed. The findings contain
minimal violations of linearity which may weaken the regression analysis; however it does not
invalidate the results (Tabachnick & Fidell, 2007). It is also reasonable to expect some slight
departures from the ideal situation due to sampling fluctuations (Tate, 1992).

Figure 9. Scatterplot unstandardized residual for MDS-R scores. The residuals are somewhat
evenly dispersed
Research question four was modified post hoc to add Moral Distress Residue as reported
by nurses who left a previous job/or considered leaving but stayed (QUITCONSID) to assess if a
better predictive model of MDS-R score could be established.
RQ4b
Which of the following characteristics (education level, total number of years working as
registered nurse, total number of years working as oncology nurse, oncology setting, oncology
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certification, ELNEC education, ethics education, participating in ethics consult, Left or intent to
leave previous job, and intent to leave the current job) are significant predictors of moral distress
in oncology nurses?
The total numbers of years in nursing and total numbers of years working in oncology are
continuous variables. All other variables were treated as categorical variables. Multiple
regression approach was identified as an appropriate tool to analyze the data gathered for this
research question. The stepwise multiple linear regression yielded a more predictive model for
MDS-R score with two predictors: (1) QUITCONSID (Left a previous job or considered leaving
but stayed); and (2) Inpatient_binary (the inpatient work setting). With this regression model
with two predictors, R2 = 0.116 as shown in Table 42 and 43. This model accounted for 11.6%
of the moral distress score variance (p= .013) compared with 4.4% using the single predictor (p=
.014) shown in the original research question and model in Table 40.
Table 42
Multiple Regression Model Summary MDS-R with Predictors Moral Residue and Work Setting
Change Statistics
Model
1
2

R
.272a
.341b

R Square
.074
.116

Adjusted R
Square
.067
.103

Std. Error of
the Estimate
41.76283
40.95140

a. Predictors: (Constant), QUITCONSID
b. Predictors: (Constant), QUITCONSID, Inpatient_binary
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R Square
Change
.074
.042

F Change
10.740
6.363

df1
1
1

df2
134
133

Sig. F
Change
.001
.013

Table 43
Stepwise Multiple Regression on MDS-R with predictors Moral Residue and Work Setting

Model

Unstandardized Coefficients
B

1
2

(Constant)
QUITCONSID

67.616
23.826

Std. Error
5.548
7.270

(Constant)
QUITCONSID
Inpatient_binary

60.925
23.556
18.329

6.053
7.130
7.266

Standardized
Coefficients
Beta
.272

t
12.187
3.277

Sig.
.000
.001

.269
.206

10.066
3.304
2.522

.000
.001
.013

RQ5
Which of the following nurse characteristic (education level, total number of years
working as registered nurse, total number of years working as oncology nurse, oncology setting,
oncology certification, ELNEC education, ethics education, and participating in ethics consults)
are significant predictors of professional moral courage in oncology nurses?
The independent variables, total numbers of years in nursing and total numbers of years
working in oncology are continuous variables. All other independent variables were treated as
categorical variables. Multiple regression approach was identified as an appropriate tool to
analyze the data gathered for this research question. Several approaches were tested to explore
the best fit. In the stepwise regression, the significance level for variable entry is set to be 0.05;
the significance level for variable removal is set to be 0.10. (An entry level significance level
was also set at 0.10 with a removal significance level of 0.15; however no additional predictors
were found). All the relevant independent variables were set as inputs for the auto selection and
removal. The regression was first conducted on the original PMCS score without any
transformation. The researcher then conducted the regression on the natural logarithm of the
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PMCS scores, (LOGNPMC). The regression result for LOGNPMC was quite similar to those
yielded in the PMCS regression.
The regression model for PMCS and total years working in oncology in Table 44 show
that a significant regression equation was found (F (1, 163) = 4.171, p = .043), with an R2 of
.025. Participants’ predicted PMCS score is equal to 5.943 + .010 (total years working in
oncology) when total years working in oncology is measured in years. The participants PMCS
score increased .010 points for each year working in oncology.
Table 44
Regression Model for PMCS and Total Years Oncology

Model
1

(Constant)
YRSONC

Unstandardized
Coefficients
B
Std. Error
5.943
.091
.010
.005

Standardized
Coefficients
Beta

t
65.236
2.042

.158

Sig.
.000
.043

With this model R2 = .025 accounted for 2.5% or an inconsequential amount of the
variance in oncology nurse professional moral courage as shown in Table 45.
Table 45
Regression Model Summary for PMCS and Years of Oncology Experience
Change Statistics
Model
1

R
.158a

R Square
.025

Adjusted R
Square
.019

Std. Error of
the Estimate
.59165

R Square
Change
.025

F Change
4.171

df1
1

df2
163

Sig. F
Change
.043

a. Predictors: (Constant), YRSONC
The regression unstandardized residuals of LogNPMC shown in Figure 10 Histogram
indicates a fairly normal distribution. The assumption of linearity was assessed with the residual
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scatterplot (Figure 11). The findings contain minimal violations of linearity which may weaken
the regression analysis; however it does not invalidate the results (Tabachnick & Fidell, 2007).
It is reasonable to expect some slight departures from the ideal situation due to sampling
fluctuations (Tate, 1992).

Figure 10. Histogram of unstandardized residuals LogNPMCS is fairly normally distributed
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Figure 11. Scatter plot of the unstandardized residuals LogNPMCS show points evenly above
and below the line.
Other Morally Distressing Situations
The Moral Distress Scale –Revised permits respondents to add at least two other
situations in which they experienced moral distress and score them. Fifty-six respondents added
a total of 60 items that were morally distressing as shown in Table 46. Of these additional items,
a majority corresponded to existing categories on the MDS-R. These categories were futile or
medically inappropriate treatments, poor communication, inappropriate pain management, and
staffing and safety concerns. There were seven additional items that potentially address new
categories of moral distress. For example, lack of care due to patient health illiteracy, not
providing best care to a dying patient when no family present, patient and family lacking
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spiritual sensitivity, failure to consult palliative care or hospice, not enough time to spend with
patients due to computer charting, and inadequate equipment or supplies to ensure safe patient
care. Due to the variability of responses, frequency and intensity scores could not be computed
for these results.
Table 46
Other Morally Distressing Situations (N= 60)
Number of
Responses
2
2
2
2
1
1
1
1
1
1
1
6
1
5
2
1
3
1
1
2
1
2
2
6
1
1

Other Morally Distressing Situations
Transporting imminently dying patients to free up a critical care
bed
Medicaid patients sent to another outpatient center
Insurance companies dictating patient treatment based on cost
Poor care to cancer patient incarcerated
Clinical trial not being offered due to time constraint/enrollment
Insurance issues uninsured or underinsured
Too many patients not enough time
Indigent patients not receiving standard care
Valuing speed over accuracy/patient safety
Supervisors put their own interest above the staff and patients
Physician unable to communicate severity of illness/afraid to tell
the family the truth
Patients want to continue chemotherapy when treatment is futile
Failure of family to recognize dying patient/disagree on EOL
decisions
Performing CPR on patient at end of life
Providers refuse to order appropriate intervention
Failure to diagnose and refer patient early for treatment
Inadequate pain medication or comfort to dying patient
Punished by leadership for reporting ethical issue
Not following NCCN guidelines
Family has false hope despite being told patient was terminal
Discontinuing feeding tube to let patient die
Family expecting a miracle
Delivering grave news without compassion or answering questions
Inadequate staffing/assigned too many patients for safe care
Inadequate staff training and orientation to new technology
Impaired colleague (drugs and alcohol)
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Corresponding
MDS-R
1
1
1
1
1
1
1
1
1
1
2
3
3
4
9
9
12
15
15
16
16
16
18
21
21
21

Number of
Responses
3
2
1
1
1
1
1
N=60

Other Morally Distressing Situations
Failure to consult palliative care or hospice for pain control
Not enough time to spend with patient due to computer charting
Lack of care due to low health illiteracy
Not providing best care to a dying patient when no family present
Patient and family lack spiritual sensitivity
Misuse of federal grant
Inadequate equipment/supplies
Items corresponding to MDS-R 1-21. Items not corresponding = 0

Corresponding
MDS-R
0
0
0
0
0
0
0

Qualitative Data Analysis
RQ6
What actions are indicative of moral courage?
To examine this qualitative question, respondents were asked specifically, “If you
experienced a morally challenging situation, describe how you took a stand for your patient;
what was the outcome of your stand; how did that make you feel?” Seventy-six (41%) of the
participants provided responses, ranging from very short to detailed, poignant descriptions. A
pragmatic qualitative approach was used for content analysis and described as an “approach of
empirical, methodological controlled analysis of text within its context of communication,
following content analytic rules and step by step models without rash quantification” (Mayring,
2000, p.5). Pragmatic knowledge in this context can be understood as established principles,
heuristics, and rules guiding the actions and decisions of the researcher during different steps of
the assessment process (Schilling, 2006). In Figure 12, the pragmatic qualitative content analysis
procedure moves in an analytical sequence from one level to the next (Schilling, 2006).
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Level 1: from
written texts to raw
data

Level 5: concluding
analyses and
interpretation

Level 2: from raw
data to condensed
procedure

Level 3: from
condensed
procedure to
preliminary category

Level 4: from
preliminary category
to coded procedure

Figure 12. Qualitative content analysis.
Level 1. From written texts to raw data. The written texts were downloaded from the
Qualtrics database into an Excel spreadsheet table, then sorted and organized around five
headings (raw data, moral challenge, moral courage/stand, feelings, and outcomes) to align with
existing categories of moral distress and moral courage frameworks guiding this study. In this
context, the raw data were examined and content was extracted and matched to one of the four
remaining headings. The researcher did not use open coding to uncover new concepts given the
scope of specific responses to the research question. All texts were anonymous and no attempts
were made to link opinions of participants toward a certain region or institution or to a response
to the questionnaire portion of the instruments.
Level 2. From raw data to the condensed procedure. The main dimensions for
categorizing data from the research question were reduced to a meaningful element or segment
of text comprehensible by itself, containing one idea, and episode or piece of information (Tesch,
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1990 as cited in Schilling, 2006) to enable an answer-focusing strategy (Schilling, 2006).
Statements that were not important to answering the question were set aside. Next, the text was
paraphrased, deleting all words not necessary to understand the statement, transforming the
sentences into a short form. For example, “it was important to support patient autonomy” was
categorized as “supporting patient’s decision; respecting autonomy.” An independent control
check was done by the research adviser (independent researcher) who has qualitative experience.
Level 3. From condensed to structured procedures and preliminary categories.
Structuring permits each statement to be attached to one of the defined preliminary category
(moral challenge, moral courage/taking a stand, feelings, and outcomes of taking a stand). In
this example, “supporting patient’s decision” was a category aligning with moral courage/taking
a stand. Interrater reliability was checked by the research adviser who made recommendations
and reorganized content to form new categories that emerged from the data to ensure that each
statement represented a single idea. Any case in doubt was checked against the original data
resulting in 100% agreement.
Level 4. From a preliminary category to coded procedures. The five dimensions of
Professional Moral Courage (Sekerka, Bagozzi and Charnigo, 2009) were used as the framework
to provide the preliminary set of codes and formal definitions for the content category. The
definitions were derived from theory and prior research to build the content category labels and
themes or subcategories. Themes and subcategories derived from the condensed statements in
level three were aligned with the five dimensions of Professional Moral Courage (Moral Agency,
Multiple Values, Endures Threat, Goes Beyond Compliance, and Moral Goal). For example, the
subcategory and emerging theme “supporting” and “risk taking” were aligned with Moral
Agency. Nurses who support, advocate for, and risk consequences to ensure patients’
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preferences and choices are followed demonstrate moral agency. If a statement implied or
demonstrated empowerment, it was classified as Multiple Values. Nurses who empowered their
patients demonstrated an ability to draw on multiple value sets such as sharing information,
sharing power, or problem solving in moral decision making and effectively sorting out and
applying strategies while holding firm to beliefs despite external concerns or demands (Sekerka
et al., 2009).
When additional concepts emerged from the data related to the five elements of the
Professional Moral Courage scale, they were linked to the most appropriate large category and
further expanded to develop the conceptualization of the category. This extended the
subcategories/themes corresponding to the segment of text resulting in 12 themes, thus
supporting the data. The researcher and research adviser agreed 100% with the final categories
and themes. A summary of the coding category is presented in Table 47 in Appendix I.
Statements that could not be categorized “misfit analysis” were analyzed. The misfit analysis
(n=10, 7.6%) did not exemplify moral courage or could not be categorized because no response
was provided. Nevertheless, a moral challenge or situational factor that affects the nurse’s
ability to act was identified by one participant who stated, “Due to being employed at that time
by a six-physician Medical Oncology office I was not able to address my concerns”. In this
example, lack of administrative support was associated with the moral challenge and inhibited
the nurse from taking the moral stand.
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Level 5: Concluding analyses and interpretation. Finally, data were used to develop an
enhanced view of the five categories used for the Professional Moral Courage Scale (Sekerka et
al., 2009). These concepts and a view of the larger experience of Moral Courage are presented in
the findings section.
Qualitative Findings
In this study, moral courage was preceded by a morally challenging situation. When
asked to describe a morally challenging situation that led to moral courage, the top four most
frequent responses clustered under patients’ perspectives or wishes not being heard, futile
treatment, poor pain control and poor provider collaboration/communication. A unifying
principle demonstrated by the oncology nurses was respect for the inherent dignity of patients
and respect for their decisions which was captured within the context of their statements. Moral
distress was triggered by the threat or violation to the fundamental principle that underlies
nursing practice. In these circumstances, nurses were aware of their duty to preserve, protect,
and support the rights of the patient. A unique finding from the perspectives of the nurses was
that patients’ wishes and preferences to stop or forgo treatment were not honored by the family
or provider. One nurse was distressed about following the family wishes instead of the patient’s,
and family putting pressure on the patient to take treatment even though the patient did not want
the treatment. Another patient wanted to stop treatment, but the spouse did not want the patient
to stop treatment and was pressuring the patient to continue treatments. A different patient
confided in the nurse outside the presence of the family that did not want to go through the
proposed chemotherapy, yet the family pressured the patient to go through with it. The nurse
revealed that working on the oncology floor it had become not at all unusual, if not common, to
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see families making decisions that met their needs rather than the needs of the patient. The
qualitative data revealed that different situations of moral distress were encountered by oncology
nurses in outpatient settings. Nurses in the outpatient setting reported ethical concerns around
informed consent and continuing with chemotherapy against the patient’s wishes.
The final themes are illustrated in the concept map in Figure 13. The five dimensions of
moral courage or taking a stand were expanded into twelve recurring themes that exemplified
moral courage in oncology nurses. These themes can be used to expand items on the
Professional Moral Courage Scale or develop a new scale.

Figure 13. Concept map of moral courage in oncology nurses.
Moral Agency was defined as a predisposition toward the moral behavior and possessing
a persistent will to engage as a moral agent (Sekerka Bagozzi, & Charnigo, 2009). The final
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themes were supporting, risk taking, and advocacy were recurring examples of courage
demonstrated by nurses in the current study.
Supporting. In displaying moral courage and standing up for the patient, several nurses
championed and reinforced behaviors that promoted patients’ autonomy. Ensuring that the
“patient received the very best care possible” was a strategy that bolstered the patient and nurse
relationship. Nurses considered the individual’s needs and established trust to ensure that the
patient’s voice was heard. One nurse stated, “It did not seem like much, but it was all I could
do.” The nurse validated the patient’s concerns and encouraged the patient to express her own
feelings by “explaining each physician’s role in her treatment and reassuring her that I had heard
everything the doctors had said” in order to help the patient make a decision. The nurse also
helped other staff appreciate that this was the patient’s will and right.
Risk taking. A few nurses demonstrated risk taking behaviors such as confronting the
physician responsible for providing unwanted continuing care at end-of-life. Being willing to act
and taking responsibility is risky. A nurse revealed that although the physician was upset, it was
rewarding to stand up for the patient and to see that his needs were met, supporting the patient’s
end-of-life decisions and stopping the treatment.
Advocacy. Oncology nurses demonstrated advocacy by representing and preserving their
patient’s best interest and upholding their patients’ wishes and preferences informing family
about current status and level of discomfort, listening to the patient, obtaining the information
needed by the patient to make decisions, and assessing the patient’s current status to
communicate openly to the physician(s). One nurse explained to the patient it was her right to
dictate the care she wanted and she did not have to take it. The patient did not want it “I walked
her back to the physician’s side so she could talk to him.”
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Moral courage was shown in nurses who incorporated supporting, risk taking, and
advocacy interventions to assure the patient’s voice was heard and acted upon to promote
responsible and appropriate decision making including minimizing unwanted or unnecessary
treatment and suffering.
Multiple Values was described as the ability to draw on multiple value sets in moral
decision making while effectively sorting out and determining what needs to be done, holding
firm to beliefs despite external concerns or demands (Sekerka et al., 2009). Despite having
moral distress, oncology nurses were resourceful and driven to do the right thing. Four recurring
themes were observed.
Enlarging the circle for decision-making. Oncology nurses demonstrated a guiding set of
principles through communication and collaboration to enlarge the circle of decision-making.
For example, moral courage was displayed by one nurse who contacted the patient’s medical
doctor who agreed to take over the patient’s end-of-life care from the oncologist. Another nurse
consulted a physician who was of the patient’s nationality to speak with the family, then with the
patient to ensure that the patient received informed consent for treatment with a full
understanding of the cancer diagnosis and prognosis. Several nurses requested and consulted
with the ethics committee. One nurse corralled the various medical staff and nursing staff caring
for the patient, including social worker and requested an ethics committee meeting.
Beyond personal values. Nurses who showed courage recognized their own emotions
and put their personal beliefs aside during the conflict to encourage the patient and family to
communicate. One nurse said she respected the patient’s decision to continue treatment, even
though “I did not agree.” Another nurse spent additional time with the patient to educate her on
the disease type and all possible treatment options and potential side effects in order to make an
87

educated decision even though the nurse personally did not agree with the patient, “it was her
right to make this decision.”
Patient autonomy. Moral courage was revealed by the nurse promoting patient autonomy
and encouraging the patient “to talk to her family and doctor about what she wanted.” The nurse
emphasized, “I talked with her about it first because she brought it up, she seemed frail, tired,
and scared; and I sensed that she might not have made her own feelings clear to her family. She
ended up going through treatment.” Nurses preserve and protect patients’ rights by assessing
their understanding of information and explaining the implications (ANA, 2015).
Patient empowerment. Oncology nurses demonstrated moral courage by empowering
their patients to make decisions. One nurse reflected on the dying process and asked the family
to put themselves in their loved one’s shoes and to consider dying in pain and suffering as death
was imminent and it was a choice to die with or without pain. The nurse recognized that respect
for human dignity begins with patients taking responsibility and being empowered to make
decisions without the control of others and enhancing the patient’s ability to act autonomously
(ANA, 2015; Anderson et al., 1995).
Enlarging the circle for decision making, beyond personal values, patient autonomy, and
patient empowerment were approaches used by nurses that demonstrate moral courage. Moral
courage in this example arises from an understanding that integrity preserving compromise
around patient decision-making involves multiple individuals to assure fair and transparent
conflict resolution (ANA, 2015).
Enduring Threat was defined as facing an ethical and moral difficulty, including both
perceived and real danger with endurance (Sekerka et al., 2009). Oncology nurses endured
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threats for their patients by standing up to power in the face of consequences in a complex
system and by conquering their fears.
Fighting for my patient in face of consequences in a complex system. In this example a
few nurses exemplified moral courage. After reading the package insert the nurse was
uncomfortable giving the medication in the outpatient setting because the risk for reaction was
great and discussed the concern with the manager who felt it was safe and therefore “we” were
going to give it. The nurse refused to give the therapy and did not obtain the patient’s consent.
However, the other nurses moved forward and gave the drug. Within 30 minutes the patient had
a reaction and was sent to the hospital. In a different scenario, the nurse called the physician and
refused to give the drug. The physician called administration but the nurse was supported by her
manager and administration. In another example, the threat escalated to a real danger when the
nurse called the legal department to support the written and verbal wishes for care communicated
by the patient and spouse as healthcare surrogate. The physician was instructed to abide by the
patient wishes. However, the physician was upset and physically knocked the office door off
the hinges looking for the nurse.
Conquering fear. In addition to assessing the ethical principle at stake (autonomy,
beneficence, non-maleficence, fidelity and justice), nurses frequently draw on inner strength and
prayer to conquer fear before taking a stand. While experiencing a morally challenging situation,
“I decide to take or not take action.” Before deciding, the nurse took a deep breath, prayed and
answered according to the patient’s conditions and needs, “she [the patient] had terminal
metastatic colon cancer and was suffering intractable pain without relief.” “The children had a
meeting with their mother and later that day they chose comfort measures only. The patient
received alleviation and died with dignity surrounded by her family members.” Doing the right
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thing for the patient was balanced by the nurses’ obligation and awareness of the moral and
ethical rights of the individual.
Going Beyond Compliance was defined as one who not only considers the rules, but also
reflects on their purpose, goes beyond compliance-based measures to consider what is right just,
and appropriate (Sekerka et al., 2009). Sharing information: getting to the meaning was an
approach demonstrated by nurses who went beyond compliance.
Sharing information: getting to the meaning. Moral courage was exemplified in nurses
who collaborated with the social worker, other nurses, and members of the palliative care team to
gain insight or perspective in dealing with family members when handling delicate issues. In
general, nurses demonstrate resourcefulness while considering what is right in a tricky situation.
One nurse revealed such skill by talking honestly about the patient’s wishes and feelings about
going to the in-patient hospice facility. “We talked and laughed and cried that afternoon/evening.
Finally I asked her frankly, what do you want to do? Do you have any desire to try chemotherapy
again?” This nurse set in motion “a lot of very upset administrators, nurses and supervisors”
because she interrupted what was “their plant to transfer the patient to hospice.”
Tricky situation. Handling tricky situations involved diplomacy or ruffling feathers. One
nurse told the physician as nicely as possible that “I had his number and I knew he was on call
the weekend. I was working all weekend and I would be calling on an hourly basis to advocate
for the patient who was moaning and writhing in the bed but not awake enough to give me a pain
level.” This showed that the nurse was acting within her responsibility and authority but was
doing so in a way to force change in approach to pain control by a physician.
Moral Goal was defined as a drive for task accomplishment that includes the use of
virtues (e.g., prudence, honesty and justice) throughout the decision making process to achieve a
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virtuous outcome (Sekerka et al., 2009). Working toward a goal becomes more important than
the activities themselves.
Truth telling: protecting the patient. Truth telling was a positive and common approach
employed by the nurse signifying the moral goal. One nurse who had cared for several
terminally ill and actively dying patients revealed that she was able to discuss with patients their
thoughts on what they wanted for their care if they suddenly stopped breathing. The nurse took a
stand for her patients by explaining the CPR protocol for a patient that becomes unresponsive in
addition to helping them by discussing end of life wishes. Another nurse stated, “Before starting
chemotherapy, I sat down with the patient, and asked him why he wanted to continue with
therapy and what he expected to achieve by doing so. The patient had the understanding that he
could be cured. I gently explained that the goal of therapy in his condition was palliation but if
receiving therapy caused him more distress and decreased quality of life, he may want to
consider forgoing therapy.” In a different scenario, the nurse was honest and candid and
suggested some questions for them to ask the physician team. Promoting advanced care
planning conversation is within the scope of nursing practice. Nurses and physicians have an
ethical and moral responsibility to ensure that patients and their healthcare surrogates receive
appropriate decision-making support and communication (Melhado & Byers, 2011). The
advanced care planning process assures treatment options are discussed including benefits and
burdens. The goal is to understand the patient’s values about treatment outcomes and assure
informed decision-making. The oncology nurses in this study normalized the experience of
moral courage by promoting informed decision-making in a caring manner to achieve the moral
goal.
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Oncology nurses showed moral courage in dealing with members of the healthcare team
and the family to voice patients’ perspectives. Raising questions about the direction of care
requires courage. A common theme expressed by these nurses was valuing patients’ right-todecide what kind of care they receive and wanting patients’ wishes to be met, not the family’s or
physician’s desires. In a few cases, taking the moral action angered the physician and did not
accomplish the desired effect from the nurse’s perspective. Patients sometimes recognize
nurses’ courage, but that was not required for the nurse to show moral courage. One patient
thanked the nurse for her honesty and bravery for going against the physician, “He said to me,”
“I know you put yourself in a tricky situation but I really appreciate what you have done for me
[sic].”
Expression of Feelings and Reflections
One nurse in an outpatient setting was distressed administering chemotherapy to a patient
with advanced Alzheimer’s but could not address her concerns due to repercussions and working
in a small oncology practice. Another nurse shared that despite undergoing several
chemotherapies and procedures for terminal metastatic colon cancer, “the patient suffered
intractable pain unrelieved by the palliative treatments”. In that scenario, the children were
distressed by the patient’s pain and suffering and asked the nurse, “what they should do” and
whether or not the nurse would continue treatment. Although oncology nurses in this study
empowered their patients and engaged other members of the team to help in communication,
some nurses have perceived emotional threats as they took moral action. Nurses who took a
stand but could not complete the transaction or morally correct action expressed a sense of failed
advocacy, fear, anger, frustration, guilt, insomnia, discomfort, and emotional pain. One nurse
who did not speak up about a patient’s perceived futile treatment felt angry, “because it appeared
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that the physician let ego play a part in the ability to defeat this disease and no one spoke at all
about quality of life, and that was wrong.” Another nurse reported that the experience was
emotionally painful to watch a patient suffer from persistent pain, watch nursing staff suffer
emotionally from watching a patient suffer, and dealing with personal feelings of not advocating
more for the patient.
Nurses who took a stand for the patient had a different reaction. These nurses reflected
on their experiences in a positive manner and felt relief, satisfaction, less stress, pride, and
happiness. One nurse reported that it was easier and less draining for the staff when everyone
was on the same page. Another summed up courage as the importance of nurses’ role in patient
care, taking action, and honoring patients by taking the right action. Taking a moral stand
requires ethical competence and a supportive ethical climate whereby nurses can carry out their
principled obligations to the patient.
While no attempt was made to match the qualitative responses to the quantitative
responses on the Professional Moral Courage Scale, these findings support that oncology nurses
do strive to take moral action and practice moral courage. The multifaceted question posed
specifically, “if you experienced a morally challenging situation, describe how you took a stand
for your patient; what was the outcome of your stand? How did that make you feel?” identified
morally challenging situations in which nurses took a stand by supporting patients’ decisions,
empowering patients to ask questions to ensure their voices were heard, risk taking and fighting
for their patients in the face of consequences, respecting patients’ autonomy, truth telling and
conquering fear. The underlying catalyst for the moral distress was not following the patients’
wishes and inadequate pain control. One nurse working in a small oncology practice
acknowledged distressing clinical situations but did not take a stand because of fear of
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retribution. Nurses who demonstrated moral courage also experienced satisfaction, relief, and
personal growth. Further exploration of the consequences of taking morally courageous stands is
needed.
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CHAPTER FIVE: DISCUSSION

Discussion of Findings
Being a full partner in healthcare requires that nurses recognize moral distress and act
courageously and professionally in addressing morally distressing clinical situations (Institute of
Medicine, 2011; Pavlish, Brown-Saltzman, Jakel, & Fine, 2014; Pendry, 2007). Studies on
moral distress have shown light on nurses’ suffering, yet how these nurses take a stand or
practice moral courage during times of distress was not clear. Moral distress can arise when
nurses’ core values to support, advocate for and protect the health, safety, and rights of the
patient are threatened (American Nurses Association, 2015; Cohen & Erickson, 2006). This
study examined the factors that influenced moral distress and the relationships between moral
distress, moral courage, and moral distress residue among oncology nurses working in adult
inpatient and outpatient settings. It also described actions of moral courage as reported by
oncology nurses. Although the model tested was not a good predictor of moral distress or moral
courage, it underscores the presence of moral distress and moral distress residue among oncology
nurses and the importance of finding ways to lessen moral distress and strengthen moral courage.
Findings from the qualitative data provide insight about how nurses act courageously in the face
of morally distressing clinical situations to ensure patients’ voices are heard.
Moral Distress
This study highlighted that oncology nurses encounter moral distress when patients do
not receive honest and ample information about their cancer diagnosis that influence patients’
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right to make choices about treatment options. The three top ranked morally distressing
responses on the MDS-R provided by oncology nurses capture their sentiments and include 1)
witnessing healthcare providers giving false hope to a patient or family, 2) witnessing diminished
patient care quality due to poor team communication, and 3) following the family wishes to
continue life support even though it was not in the best interest of the patient.
The independent-samples t test comparing the Moral Distress mean scores of oncology
nurses in inpatient and outpatient settings found a significant difference between the means of
the two groups. Oncology nurses working in inpatient settings had higher levels of moral
distress than their counterparts in outpatient settings. Although, the difference in moral distress
levels between work settings was statistically significant when entered into the regression model,
it was a weak predictor of moral distress. This finding may suggest that the MDS-R instrument
did not encompass all of the sources of moral distress encountered by oncology nurses as
evidenced by the specific examples reported by the nurses in the study. Another possible
explanation is that outpatient oncology nurses may have alleviated moral distress by changing
from an inpatient setting to a less stressful setting. Nurses in an inpatient setting tend to
encounter patients with higher comorbid conditions and poorer outcomes than those achieved in
an outpatient setting (Lubell, 2012). Poorer outcomes in hospitalized patients were associated
with insufficient resources, including inadequately trained personnel (Robinson & Beyer, 2010).
Even though most chemotherapy is administered in the outpatient setting, patients who
experience severe side effects often end up in the emergency room or admitted to the hospital.
For example, many patients experience prolonged hospitalizations and recurrent admissions
associated with treatment side effects (Fitch & Pyenson, 2010). Still the work setting accounted
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for a minuscule portion of the variance suggesting that other factors and personality of the nurse
need to be considered.
Though previous studies found significant differences in levels of moral distress between
professions and work units in which nurses and other direct care providers (physicians, case
managers, social workers, respiratory therapists) had the highest level of moral distress, work
unit was not a predictor of moral distress (Allen et al., 2013; Whitehead et al., 2015). Allen et al
(2013) reported differences in moral distress across disciplines associated with responsibilities of
each discipline and work dynamics. Similar patterns across disciplines were also reported by
Whitehead et al. (2015) suggesting that levels of moral distress were related to the ethical culture
and work environment. Additional studies found high levels of moral distress for nurses
associated with following the family’s wishes to continue life support even though it was not in
the patient’s best interest (Allen et al., 2013; Winland-Brown, Chiarenza, & Dobrin, 2010).
Winland-Brown et al. (2010) reported a significant finding for following the physician’s order
not to tell the patient the truth when he/she asked for it. Researchers examining truth telling and
how physicians inform patients with serious illness of their diagnoses and how much information
patients want, found that the vast majority of patients responded that they had a right to know
their condition and to be informed by the provider of a life threatening illness and prognosis
(Punjani, 2013; Sullivan, Menapace, & White, 2001). Nurses also believed that patients had a
right to be told the truth about their illness by the physician (Sullivan, Menapace, & White,
2001). Not abiding by patients’ wishes can perpetuate a culture of false hope, power inequality
and moral distress rather than promote team collaboration and honest communication around the
patients’ goals and preferences (ANA, 2015; Pavlish, Brown-Saltzman, Fine, & Jakel, 2015).
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No statistically significant differences were found between nurses’ characteristics (age,
education level, certification, ELNEC training) and moral distress in this study. Though nurses
with a bachelor’s degree had higher Moral Distress scores compared with other levels of
education, neither education, RN experience, nor oncology certification were found to be
predictors of moral distress in this study. Other researchers found significant relationships
between end-of-life education and moral distress (Whitehead et al., 2015), and level of education
and moral distress (Sirilla, 2013) but none were predictors of moral distress. Sirilla (2013)
reported a negative but significant relationship between moral distress and education level and
work units, concluding that the addition of separate ethics courses at higher education levels
yielded greater confidence in decision-making for these nurses.
In this current study, while oncology nurses who took a separate ethics course had an
overall higher mean moral distress score than nurses who did not, the ANOVA test results in
Table 23 indicated that such a difference was not significant. The post hoc η2= .03 was small
indicating that a larger sample size or a minimum of 53 participants per group was needed to
achieve statistical significance. With the convenience of online nursing programs, it is
speculated that nurses who take separate ethics courses as a requirement of a bachelor or
graduate degree likely learn within an interdisciplinary environment where sharing of workrelated experiences can provide an opportunity for reflection, feedback, and problem solving.
Another study examining relationships between ethics education, moral action, and confidence
found a significant relationship between the variables, suggesting that ethics education positively
influenced nurses’ confidence in ethical decisions and moral action (Grady, Danis, Soeken,
O’Donnell, et al. 2008).
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With ethics education, nurses are aware of their role and responsibility and become more
distressed when those values do not align with the moral action (Winland-Brown et al., 2010). A
similar relationship between moral distress and having taken a prior ethics course was also found
by Winland-Brown et al. (2010); respondents had a significantly higher amount of moral distress
compared with those who had not taken any ethics’ courses. Winland-Brown et al (2010)
concluded that nurses were likely able to react with the skill set and knowledge when dealing
with morally distressing situations rather than becoming frustrated or quitting their jobs. Those
who take ethics courses are alerted to situations that are unethical and learn conflict resolution
and how to work through an ethical dilemma or to request an ethics consult. The type of ethics’
education and how the content is assimilated into the work setting raise additional questions. For
example abstract concepts and practical applications must be integrated in the practicum and
clinical rotation so that nursing students and nurses advancing their education have an
opportunity to discuss ethical situations in the work setting and develop conflict resolution.
In the current study oncology nurses identified several situations in the work setting that
were morally distressing by writing in a total of 60 items at the end of the MDS-R scale (see
Table 46). Seven items potentially represent and address new categories of moral distress in the
oncology setting. These items include: lack of care due to low health literacy; not providing best
care to a dying patient when no family present; patient and family lacking spiritual sensitivity;
failure to consult palliative care or hospice; not enough time to spend with patients due to
computer charting; and inadequate equipment or supplies to ensure safe patient care.
Additionally, nurses who provided qualitative responses and recounted morally
distressing situations confirmed previous findings in the literature. Oncology nurses’ qualitative
experiences enriched the quantitative findings. For example, nurses reported a majority of
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situations in which the patient was pressured by the family or physician to continue
chemotherapy treatment even though the patient had voiced a desire to stop treatment. Some
patients’ wishes and preferences to stop or forgo chemotherapy treatment were not honored by
the family or physician. An oncology nurse said, “An elderly woman diagnosed with breast
cancer felt pressured by the physician to have treatment she did not want.” Oncology nurses
also described several situations involving patients that did not want life support at end-of-life
but, the patient’s wishes or health care surrogate was ignored, prolonging medically
inappropriate treatments, inadequate pain control, poor provider communication and
collaboration, delays in discussing prognosis and Do Not Resuscitate orders (DNR), giving false
hope, patient safety and confidentiality concerns, and improper consent. Other studies have
reported similar perspectives whereby the family member minimized patients’ concerns and
parents directed all the care decisions and either threatened to discontinue insurance or forced the
older child to sign over decision making rights (Pavlish, Brown-Saltzman, Jakel, & Fine, 2014).
In this current study, the ethical challenge was the catalyst that activated the moral action.
Although ethical challenges can provide opportunities to have dynamic and positive
conversations around patient goals, the presence of moral distress indicates insufficient conflict
resolution (Epstein & Delgado, 2010). Nurses have a moral obligation to be familiar with and
understand the moral and legal rights of patients (ANA, 2015) and to uphold the nursing code of
ethics
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Moral Courage
This current study provided a primary focus on moral courage in oncology nurses. Both
the quantitative and qualitative findings as experienced by nurses in oncology settings expand
the science of moral courage and suggest areas to revisit on Sekerka’s et al. (2009) Professional
Moral Courage Scale [PMCS]. The results show a weak positive significant correlation between
total years working in oncology and PMCS. Total years’ working in oncology predicted a small
amount of the Professional Moral Courage score. Nurses with more years of oncology work
experience tend to act with professional moral courage. One logical inference is that as nurses
become more experienced and comfortable with administration of chemo drugs and side effects
they can anticipate what orders are needed and communicate with the physician efficiently.
Although oncology nurses working in inpatient setting had higher moral distress scores, there
were no significant differences in PMCS scores related to work settings, which may suggest that
nurses are aware of their moral obligations regardless of work setting but cannot always take the
correct moral action. Inpatient nurses were slightly younger in age (M = 49.6, SD = 10.82, R =
25-68) compared to those in the outpatient setting (M = 52.7, SD = 9.92, R = 29-79) which may
suggest that the more mature nurses prefer a shorter work day or over a period of time were less
concerned about the ramification and risk of standing up with courage. It is also conceivable that
inpatient oncology units have a greater turnover of patients and readmissions rates whereby
greater numbers of morally distressing situations are likely to take place. Regardless, these are
complex issues. No doubt other factors or variables such as leadership support and training in
moral courage may explain and predict professional moral courage. How these skills are
cultivated in the work setting needs further investigation.
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Raising questions about the direction of care requires courage. Nurses are frequently in a
“catch 22” or difficult situation where they witness the emotions of the patient and family for
which there is no easy solution. Yet, observing patients suffer because of poorly controlled pain
became the catalyst for moral action by oncology nurses in this current study. These nurses
accepted their moral obligation to advocate for the patient, both educating the family and
persuading the physician that the patient’s voice needed to be heard. In this scenario, the nurse
was assertive and told the physician she would continue to call until the patient’s pain was
relieved. As nurses develop a more active voice in collaboration with physicians, assertiveness
training among nurses might decrease moral distress and enhance moral courage.
Palliative chemotherapy treatment is unable to cure cancer but intended to decrease
symptoms, tumor burden, control pain, and prolong life (Houlihan, 2015). Previous studies
reported that inadequate pain control for the patient was associated with emotional suffering for
nurses who were angered and frustrated (Bernhofer & Sorrell, 2015; Pavlish et al., 2014) by the
physician’s refusal to increase the pain medication. When patients continue to suffer despite
nurses’ best efforts to get the right medication and appropriate dose to alleviate pain, studies
reported that nurses may feel powerless or experience a threat to their own moral integrity
(Epstein & Delgado, 2010). Nurse barriers have also been associated with difficulty
communicating with or obtaining orders from the provider (Bernhofer & Sorrell, 2014).
Nevertheless, patients have a moral and legal right to have their pain managed and to determine
what will be done including a choice of no treatment and to be given support through the
decision making process (ANA, 2015). Such considerations must respect the patient’s decisions
and does not require the nurse to agree with or support all choices made by the patient (ANA,
2015).
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Even so, findings in this study reveal that oncology nurses who displayed moral courage
and took a stand also expressed feelings of relief, satisfaction, pride, less stress and personal
growth. A fundamental principle demonstrated by oncology nurses in the study was that they
valued patients’ rights to decide what kind of care they receive and they strived to adhere to the
patients’ preferences. A significant finding, total years in nursing experience was a weak
positive correlation with Endures Threats (subscale) on the PMCS. This finding may suggest or
support the idea that nurses with more years of nursing experience may take on the responsibility
for breaking the bad news. The oncology nurses who responded to the qualitative question in
this study provided insight about their moral courage. These nurses displayed moral virtue and
had an active role by means of supporting the patient, risk taking, advocacy, enlarging the circle
for decision-making, putting aside personal beliefs, respecting patient autonomy, empowering
the patient, fighting for the patient in face of consequences in a complex system, sharing
information, getting to the meaning, handling tricky situations, protecting the patient and truthtelling (see Table 47). This study also revealed that nurses sometimes express justifiable anger at
physicians who failed to communicate the severity of illness or tell the family the truth. One
nurse was honest and candid and suggested some questions for the patient and family to ask the
physician. Truth-telling was done in a sensitive and compassionate manner while supporting the
patient and family. If the nurse judges that the patient should have information that is the
physician’s primary responsibility to communicate, and the physician fails to disclose the
information, the nurse has a moral responsibility either to communicate that information or see
that the information is communicated to the patient (Jameton, 1984, p. 175). In addition to
assessing the ethical principle at stake, the nurse frequently draws on inner strength and prayer or
the use of spirituality for moral courage, conquering fear before taking a stand. Doing the right
103

thing for the patient was balanced by the nurses’ obligation and awareness of the moral and
ethical rights of the individual (ANA, 2015).
Participants in this study demonstrated moral courage in dealing with members of the
healthcare team and the patient’s family to give voice to the patient’s perspective. Nurses
practice with moral courage when they confront situations that pose a direct threat to patient care
(LaSala, & Bjarnson, 2010). Oncology nurses used risk-taking tactics to take a stand. Such
action was taken by the nurse who confronted the physician responsible for providing unwanted
ongoing care at end of life. Being willing to act and taking responsibility is risky. One nurse
revealed that the physician was upset, but it was rewarding to stand up for the patient and to see
that the needs were met, supporting the patient’s end of life decisions and stopping the treatment.
Wiegand and Funk (2012) did not measure moral courage, but observed a similar phenomenon
when some nurses tried to intervene to ensure that patients’ preferences were followed however,
their voices were not heard. Though a few nurses were successful in their intervention and
influenced the patient outcome, a majority said they would not intervene in the future (Wiegand
& Funk, 2012). Still, moral distress can be the catalyst for positive change and help nurses
achieve moral courage.
There was a weak negative but not significant relationship between the Moral Distress
and Professional Moral Courage scores, indicating that higher Moral Courage scores were not
related to lower Moral Distress scores. Fundamental to the moral distress argument is the
perceived inability to act on one’s moral obligations and values (Whitehead et al., 2015).
However, an important finding in this study was that nurses were able to take the moral action
and set aside their own differences. Sekerka et al (2009) suggested that moral agents or
individuals who adhere to moral values are aware that their position, identity, and character may
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be at risk. However, moral agents manage their emotions and balance their desire to proceed
with the action against other competing threats (Sekerka et al., 2009). Moral courage was also
manifested in examples of patient advocacy in the face of fear and retribution (Lachman, 2007a).
In this study, a nurse in the outpatient setting refused to give the chemotherapy after
reading the package insert because the risk for reaction was high in that patient but was not
supported by the manager. In a different case, the nurse called the legal department to support
the written and verbal wishes for care that was communicated by the patient and healthcare
surrogate. However, the case escalated to a real danger, “the physician was upset and used
physical force to communicate disapproval with the nurse.” Outcomes of courage also include
acting in the patient’s best interest by alleviating pain or suffering, communicating with patients
and family openly, and collaborating with physicians effectively (Hawkins & Morse, 2014).
Regardless of the actual or perceived threat, nurses who stand up and act accordingly
when their moral principles are threatened demonstrate moral courage (Lachman, Murray,
Iseminger, & Ganske, 2012). Handling a delicate situation was described by the nurse who
informed the attending physician of the patient's expressed wishes but the physician persisted in
starting treatment. “I initiated a consult to the Ethics Committee as I was acting as my patient's
advocate. I knew it was my role as a nurse to take the actions that I did. For that, I am grateful
that I was able to be this patient’s advocate.”
Despite experiencing levels of moral distress, the nurse demonstrated support and respect
for the patient’s decision-making and autonomy. Patient autonomy was exemplified by one
nurse who said, “it did not seem like much, but it was all I could do, explaining each physician’s
role in her treatment and reassuring her that I had heard everything the doctors had said and
could help her explain to family members due to arrive that evening, encouraging her to write
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down questions as she thought of them so that she could be ready for the doctors when they came
in the next morning.” In this example, the nurse took an active role to ensure that the patient was
well-informed to decide on a plan of care from a realistic set of options that aligned with the
patient’s goals and preferences (Sherner, 2016). Only one nurse reported that she was not able to
take a moral stand due to the ethical climate in her office and fear of ramification. Previous
studies found a negative correlation between moral distress and ethical climate. The ethical
climate is defined as the organizational culture and processes that support open discussion and
resolution of ethical decisions (Hamric & Blackhall, 2007). The more ethically supportive the
work environment the lower the moral distress, suggesting that the quality of the ethical climate,
conflict resolution and support for staff are influenced by other factors that do not necessarily
explain the differences in moral distress (Hamric, Borchers, & Epstein, 2012; Whitehead et al.,
2015).
The uncertainty in prognostication often makes it difficult for physicians to discuss end
of life options and to stop treatment (Barclay & Maher, 2010). This view supports the current
assumption that dynamics beyond nurses’ control were associated with the most moral distress.
However, qualitative responses provided by several nurses in this study were reflective and they
did not perceive themselves as passive bystanders. A few respondents reported that the morally
distressing experience gave them an opportunity to re-evaluate their own values and beliefs.
Nurses practicing with moral courage know that addressing these issues is leadership in action
(LaSala, & Bjarnason, 2010) and these qualities must be cultivated to show effectiveness. This
data will lead to instrument development that will better measure the issues for oncology nurses.
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Moral Distress Residue
In this study, moral distress residue manifested as guilt, anger, fear, emotional pain, and
frustration. For example, one nurse said it was difficult not to internalize anger and frustration
toward the “decision-makers.” A different nurse shared, “for me it was emotionally painful to
watch a patient suffer from persistent pain, watch nursing staff suffer emotionally from watching
a patient suffer and dealing with my own feelings of not advocating more for the patient.” These
remarks may support the idea that cumulative effects of unresolved moral distress result in moral
distress residue (Webster & Baylis, 2000) which can negatively impact emotional responses and
nurses’ practice. These findings were similar and support previous studies that moral distress
has negative consequences such as anger, suffering, sadness, grief, guilt, and stress (Gutierrez,
2005; Wiegand & Funk, 2012).
The quantitative results demonstrate that oncology nurses experienced moral distress
residue. Nurses who left a previous job (26%) and those who considered leaving (28%) reported
statistically significantly higher mean Moral Distress levels than those who had not considered
leaving. The intent to leave a current job has important implications for nursing leadership. In
this study, oncology nurses (17%) who are currently considering leaving their jobs due to the
way patient care is handled at their institutions have the highest Moral Distress mean scores and
the lowest Professional Moral Courage scores. Having left or considered leaving a past job was
an indirect or proxy indicator of moral residue, but intent to leave a current position was more
about current levels of moral distress (A. B. Hamric, personal communication, November 9,
2014). These findings were similar to and support those of previous studies (Allen et al., 2013;
Cavaliere, Daly, Dowling, & Montgomery 2010; Corley, Elswick, Gorman, & Clor, 2001;
Lazzarin, Biondi, & DiMauro, 2012; Maningo-Salinas, 2010; Sirilla, 2014). As such, when
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nurses experience unresolved moral distress, healthcare systems are impacted by the negative
consequences, because nurses leave the profession or seek less stressful jobs (Ritenmeyer &
Huffnan, 2009). Regardless, attention must be given to job-related conditions in which moral
distress occurs with a focus on interventions that support moral courage and lessen moral
distress.
Moral Agent Conceptual Framework
The conceptual framework tested in this study confirmed that morally challenging
situations (patients’ wishes not being heard, medically inappropriate or futile treatments,
inadequate pain control, poor provider collaboration and communication, disregard or delays in
discussing prognosis and DNR, false hope, time constraints, confidentiality, and inappropriate
informed consent) preceded experiences of moral distress and moral courage. The most
challenging situation experienced by these nurses was associated with the patients’ wishes not
being heard by the family and providers. In general, work setting was a weak predictor of moral
distress and total years working in oncology was a weak predictor of moral courage. Nurse
characteristics as predictors of moral distress and moral courage (such as education level,
professional certification, End of Life Nursing Education) were not supported in the model and
had no influence on Moral Distress and Professional Moral Courage scores, which suggests that
other variables contribute to this phenomenon.
Nurses with the highest levels of moral distress were more likely to experience moral
distress residue with unresolved or repeated encounters of moral distress and leave a current job.
It is not known whether an activity directed at building moral courage skills will improve moral
courage or impact moral distress residue. A pre-test, post-test design using the Professional
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Moral Courage Scale could measure the impact of a moral courage training activity on moral
courage over time. The qualitative responses from this study can to refine the conceptual model
and Professional Moral Courage Scale to use in future studies to evaluate moral courage in
oncology nurses. The qualitative question in this study did not address barriers to moral courage
which should be identified and included in the model.
Policy Implications
Oncology nurses are important members of the interdisciplinary team. Open
communication and collaboration between physicians and other members of the team, including
patients and their family members are fundamental to quality care and patient safety. Emphasis
on high quality care and delivery models that are patient-centered and adheres to the patient’s
preferences must be grounded in moral courage and professionalism that recognizes and supports
high standards of practice (Fasoli, 2010). Nurses and healthcare administrators must align
professional practice models with changes in system level processes that support and encourage
a collaborative decision-making environment, rather than a paternalistic process that favors onesided decision-making and ignores concerns (Pavlish et al., 2015).
Given rising healthcare costs and evidence about the financial burdens experienced by
cancer patients (Donley & Danis, 2011), it is reasonable to balance healthcare costs with
thoughtful considerations that respect patients’ choices. Offering patients the choice of less
expensive palliative care rather than unwanted treatments may also help to reduce morally
incongruent care. Discussing personal care preferences with cancer patients will ensure that
these patients receive the type of care they desire (Mack, Weeks, Wright, Block, & Prigerson,
2010).
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Furthermore, nurses are ready to leave their job when situations contributing to moral
distress do not get resolved and they cannot act on their professional judgement. The link
between moral distress and leaving a job supports the need to minimize moral distress to
improve nurse retention (Whitehead et al 2015).
Oncology nurses who do exhibit moral courage also need support from nursing
leadership. Nurse educators and nurse leaders must begin to cultivate moral courage and educate
nurses and future nurses the competencies to recognize and effectively deal with moral distress
in the work setting without negative ramifications. Moral distress does not have to be an
occupational hazard of healthcare. Healthcare leaders must create an interdisciplinary bioethics
competency-based curriculum for nurses, physicians, and other healthcare professionals to assure
a stable work force and safe ethical environment that supports open dialog, moral courage, and
problem resolution.
Nursing Implications and Research Recommendations
Few nurses in this study activated a consult to the ethics committee. Nurses’ stories
concerning their experiences with ethics consultations or committees may suggest that the
process was unfamiliar to them and some nurses had a negative experience (Pelton,
Bohnenkamp, Reed, & Rishel, 2015). Nurses who have taken ethics content in their nursing
programs correctly identify morally troubling situations but may feel unsupported in their work
settings, which adds to the moral distress. Validate that nurses are familiar with the ANA Nurses
Code of Ethics (ANA, 2015). Establish that nurses know and understand the process for
obtaining an ethics referral to ensure timely referrals. Ensure that the Ethics Group is
represented by staff nurses and visible on oncology units where these situations are likely to
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occur. Create a proactive process to identify and discuss difficult cases on the unit to normalize
the experience and show support for both nurses and providers.
Train physician-nurse champions in conflict resolution in both the inpatient and
outpatient settings to address ethical concerns toward improving the ethical climate. This dyad
could launch a weekly or monthly journal club using current articles from the oncology and
bioethics literature to stimulate open discussion, integrate evidence based practice and promote
positive change. Create a support group or one-on-one mentoring program where more
experienced nurses in the outpatient setting can provide newer nurses a safe environment to learn
leadership and moral courage skills to ensure that patients’ preferences and voices are heard.
Identifying barriers to moral courage and testing the predictive ability is needed so that strategies
and interventions can test moral courage outcomes. The model could be used in other care
settings as a framework to test different interventions and relationships. For example, the box
representing nurse characteristics in the framework could be replaced with an educational
intervention using control and experimental groups to test the intervention and relationship or
influence on moral distress and moral courage. The model and recommendations discussed in
these finding should be tested in future studies.
Nurse leaders, quality and safety councils, risk managers, and administrators must
acknowledge that moral distress is present in the work setting and be proactive by including
training and skilled conversations regarding end of life care, code status and advance care
planning into the nurses’ orientation to the unit and annual competencies. Nurses must also be
aware of their actions and preserve, protect, and support rights of the patients even if they
disagree (ANA, 2015). Further efforts are needed to educate the public about appropriate care to
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safeguard the patient from harmful or undesired treatments that may not be medically
appropriate in advance stages of illness and increase suffering at end of life.
Studies are needed to test different approaches that mitigate moral distress and bolster
moral courage. Certain situations contributing to moral distress, such as lack of time to discuss
patient goals, violation of patient confidentiality, and inappropriate informed consent are
problematic and require immediate attention and resolution. Being honest without taking away
hope (Pavlish, Brown-Saltzman, Jakel & Fine, 2014) requires skill. Regardless, nurses should
expect to have goals of care conversations with patients about their values and preferences,
which then need to be conveyed to and respected by members of the healthcare team. To start,
develop quarterly ethics case reviews and presentations derived from practice that focus on
recognizing, analyzing, and taking action. The case reviews and presentations must include
practical and interactive bioethics, utilizing role playing and problem-solving strategies.
Edmonson (2015) tested a pretest-posttest intervention to develop moral courage in 16 nurse
leaders using the Balance Experiential Inquiry (BEI) framework and past experiences for
reflective learning to gain an understanding of what promoted or curtailed participants’ ability to
respond to ethical issues. BEI incorporates an andragogic philosophy of adult learning, in which
participants who experienced an ethical dilemma reflected on the experience, reasoned abstractly
about the experience, and then acted and experimented with newly acquired behaviors
(Edmonson, 2015; Sekerka, Godwin, & Charnigo, 2012).
Another strategy is monthly journal club activities using literature and evidence based
approaches that can be incorporated into the unit or outpatient learning activities to encourage
interdisciplinary team participation and collaboration between nurses and providers that nurture
moral courage. Nurse leaders and nurse educators will need to develop expertise in the concepts
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of moral literacy and best practices for teaching moral courage so that current and future nurses
are able to contribute to their ethical climate in a confident and healthy manner (Edmonson,
2015).
Although healthcare organizations have begun to undertake changes in policies and
practices to empower healthcare professionals with the goal of improving communication and
collaboration (Browning, 2013), role-playing morally challenging clinical situations and moral
courage in health care settings will provide greater opportunities to practice effective team
communication and interdisciplinary education on these topics to enhance the learning
experience for staff and students that build team collaboration and moral courage. Assertiveness
training to improve nurse-physician communication (Curtis, Tzannes, & Rudge, 2011) and role
playing interventions are likely to normalize levels of moral distress and could be tested using an
experimental design. Work settings that focus on improving the ethical climate are likely to
lessen the experience of moral distress and help to maintain a stable workforce and nurse
retention. In addition, this study should be replicated and the moral courage scale should be
tested in a different population of nurses. Further study or improved measurement is needed to
uncover the relationships among such variables. Thus, future work should go beyond this. For
example, there are likely personality traits that predispose individuals to experience distress (like
neuroticism) and also to show moral courage (conscientiousness).
Limitations
Threats to validity affect the generalizability of the findings to other samples, settings and
practice (Polit & Beck, 2012). This study has limitations to both internal and external validity.
The convenience sample recruited for this study was drawn from the Oncology Nursing Society
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national membership, representing two regions and was not a random sample. Although the
online survey was electronically mailed to over 2,400 members, the response rate was 11%,
which could suggest that the topic was divisive or not relevant to the recipient. Additionally,
self-selection raises potential for bias. A higher number of nurses with more than an Associate’s
degree participated in the study and may suggest that nurses with professional affiliation in ONS
tend to have advanced degrees which was higher than similar studies. Nevertheless, e-mail and
online survey response rates varied from 8% to 11% (Hunter, 2012) and often fall far below 30%
(Sheehan, 2008). A disadvantage of this recruitment method is that only members of the
national organization are invited to participate, therefore, generalizability to other settings is a
limitation.
Another limitation is that the MDS-R instrument has not been tested in the outpatient
specialty clinical areas, such as outpatient oncology (Hamric et al., 2012) and may not have
captured the essence of situations relevant to participants in that environment. However,
context-specific situations of moral distress found in this study could be used to develop an
appropriate measure for clinicians in the outpatient oncology setting. At the time of this study,
no studies were found that included use of the PMCS in an oncology nursing sample. Although
the instrument demonstrated good internal consistency with a Cronbach alpha of .89, the PMCS
scores ranged from 4.47 to 7.0 points with a mean score of 6.10 which may suggest that the scale
has a high social desirability bias. Respondents may have answered questions in a manner that
was viewed favorably by others. The PMCS scores in the study are also very high which may
indicate a ceiling effect which makes discrimination among subjects at the top end of the scale
difficult. The study should be replicated in a different sample of oncology nurses. Additionally,
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the self-reported moral courage in the qualitative portion was not matched to the same
participant’s moral distress, which could be evaluated in a future study.
Gender and diversity of the sample were also limitations, representing 3% males, 2%
Asian, 4% Hispanic, and 13% African Americans. Because of the small group sizes, differences
between the groups could not be determined. More males and higher participation among
diverse ethnic groups are needed to be more in line with population diversity in future studies as
their perspectives on moral distress and moral courage are missing in the literature. According to
a 2014 survey by the Health Resources and Services Administration (HRSA), the nursing
workforce for males represents 9%, reflecting a 12.5% increase since 2000 (American Nurses
Association, 2014).
Another limitation was that the qualitative question did not elicit barriers to moral
courage, which would have been important to assess. It was just by chance that one person
answered in a way that addressed this. Additionally, Schilling's pragmatic method used in the
qualitative data analysis does not as much encourage expansion of conceptual development it is
more confirmatory.
Conclusion
The current study reveals that moral distress among nurses is present in the oncology
setting. Nurses in inpatient settings had higher moral distress levels than in outpatient settings.
However, nurses in outpatient settings identified situations that are pertinent to the outpatient
setting such as insufficient informed consent and pressuring patients to start or continue therapies
that warrant future investigation. Despite levels of moral distress, oncology nurses displayed
moral courage by supporting the patient, risk taking, advocacy, enlarging the circle for decision

115

making, empowering the patient, fighting for the patient in the face of consequences in a
complex system, sharing information and truth telling. Moral courage is a learned quality of
moral character that influences individuals to do the right thing (American Nurses Association,
2015). Therefore, ongoing education in ethics derived from clinical practice provides a
foundation for nurses to create, maintain, and contribute to morally acceptable environments that
enable nurses to be morally courageous (ANA, 2015). Nonetheless, for moral courage to
flourish, nurses must be supported by a moral environment that enables open communication,
collaboration, respect, and transparency (American Association Nurses, 2015). Nurses are
important contributors to their work environment, and transformation of the practice
environment not only requires safe quality care, but must assure that the patients’ voices are
heard. Nurses should expect to participate in honest dialog with patients, families and members
of the healthcare team in order to align with the patient’s preferences, realistic treatment goals,
and outcomes.
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APPENDIX A: APPROVAL OF EXEMPT HUMAN RESEARCH
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APPENDIX B: ONCOLOGY NURSING SOCIETY APPROVAL
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February 25, 2015

Hi Lolita,
Your list rental has been approved by the ONS Research team. When would you
like to send this out? You say you’d like to send this to members in FL and GA- how
many would you like to send? I’ll also need a subject line for the email, and a survey link.
Finally, I’ll need payment. I can take a credit card or check.
Thanks! Kristina
Kristina Gantner
Marketing Coordinator
Oncology Nursing Society
125 Enterprise Drive
Pittsburgh, PA 15275-1214
+1-412-859-6235 (phone)
+1-412-859-6164 (fax)
kgantner@ons.org
www.ons.org
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APPENDIX C: MORAL DISTRESS SCALE-R (MDS-R)
NURSE QUESTIONNAIRE (ADULT)
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Moral Distress Scale Revised – Adult
Moral distress occurs when professionals cannot carry out what they believe to be ethically appropriate
actions because of internal or external constraints. The following situations occur in clinical practice. If you have
experienced these situations they may or may not have been morally distressing to you. Please indicate how
frequently you experience each item described and how disturbing the experience is for you. If you have never
experienced a particular situation, select “0” (never) for frequency. Even if you have not experienced a situation,
please indicate how disturbed you would be if it occurred in your practice. Note that you will respond to each item
by checking the appropriate column for two dimensions: Frequency and Level of Disturbance.
© 2010, Ann Baile Hamric All Rights Reserved

Frequency
Never Very frequently
1
1. Provide less than optimal care due to pressures from
administrators or insurers to reduce costs.
2. Witness healthcare providers giving “false hope” to a
patient or family.
3. Follow the family’s wishes to continue life support
even though I believe it is not in the best interest of the
patient.
4. Initiate extensive life-saving actions when I think
they only prolong death.
5. Follow the family’s request not to discuss death with
a dying patient who asks about dying.
6. Carry out the physician’s orders for what I consider to
be unnecessary tests and treatments.
7. Continue to participate in care for a hopelessly ill
person who is being sustained on a ventilator, when no
one will make a decision to withdraw support.
8. Avoid taking action when I learn that a physician or
nurse colleague has made a medical error and does not
report it.
9. Assist a physician who, in my opinion, is providing
incompetent care.
10. Be required to care for patients I don’t feel qualified
to care for.
11. Witness medical students perform painful
procedures on patients solely to increase their skill.
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Level of
Disturbance
Great extent

None
1

2

3

4

0

1

2

3

4

Frequency
Never Very frequently
1

Level of
Disturbance
Great extent

None
1

2

3

4

0

12. Provide care that does not relieve the patient’s
suffering because the physician fears that increasing the
dose of pain medication will cause death.
13. Follow the physician’s request not to discuss the
patient’s prognosis with the patient or family.
14. Increase the dose of sedatives/opiates for an
unconscious patient that I believe could hasten the
patient’s death.
15. Take no action about an observed ethical issue
because the involved staff member or someone in a
position of authority requested that I do nothing.
16. Follow the family’s wishes for the patient’s care
when I do not agree with them, but do so because of
fears of a lawsuit.
17. Work with nurses or other healthcare providers who
are not as competent as the patient care requires.
18. Witness diminished patient care quality due to poor
team communication.
19. Ignore situations in which patients have not been
given adequate information to insure informed consent.
20. Watch patient care suffer because of a lack of
provider continuity.
21. Work with levels of nurse or other care provider
staffing that I consider unsafe.
If there are other situations in which you have felt moral
distress, please write them and score them here:

Have you ever left or considered quitting a clinical position because of your moral distress with the way
patient care was handled at your institution?
No, I’ve never considered quitting or left a position ______
Yes, I considered quitting but did not leave ______
Yes, I left a position ______
Are you considering leaving your position now? Yes ___ No ___
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Sekerka et al. Professional Moral Courage Scale
Evaluate the statements as they pertain to you at work, on a scale from 1 (never true) to 7
(always true).
Never
Sometimes
Always
1
2
3
4
5
6
7
Theme 1
_____ 1. I am the type of person who is unfailing when it comes to doing the right thing at work.
_____ 2. When I do my job I regularly take additional measures to ensure my actions reduce
harms to others.
_____ 3. My work associates would describe me as someone who is always working to achieve
ethical performance, making every effort to be honorable in all my actions.
Theme 2
_____ 4. I am the type of person who uses a guiding set of principles from the organization as
when I make ethical decisions on the job.
_____ 5. No matter what, I consider how both my organization’s values and my personal values
apply to the situation before making decisions.
_____ 6. When making decisions I often consider how my role in the organization, my boss
(supervisor or leader), and my upbringing must be applied to any final action.
Theme 3
_____ 7. When I encounter an ethical challenge I take it on with moral action, regardless of how
it may pose a negative impact on how others see me.
_____ 8. I hold my ground on moral matters, even if there are opposing social pressures.*
_____ 9. I act morally even if it puts me in an uncomfortable position with my superiors.*
Theme 4
_____ 10. My coworkers would say that when I do my job I do more than follow the regulations,
I do everything I can to ensure actions are morally sound.
_____ 11. When I go about my daily tasks I make sure to comply with the rules, but also look to
understand their intent, to ensure that this is being accomplished as well.
_____ 12. It is important that I go beyond the legal requirements but seek to accomplish tasks
with ethical action as well.
Theme 5
_____ 13. It is important for me to use prudential judgment in making decisions at work.
_____ 14. I think about my motives when achieving the mission, to ensure they are based upon
moral ends.
_____ 15. I act morally because it is the right thing to do.*
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Nurse Demographic and Characteristics
To help me interpret your responses, please provide the following information. As with your answers to the
other portions of this survey, your responses will be kept confidential.
1) What is your age? _____________ Years
2) Gender: ______________
3) What is your racial or ethnic background? ___________________________________
4) What is your highest education level in nursing?
Diploma in nursing __
Associate degree in nursing __
Bachelor degree in nursing __
Master’s degree in nursing __
Doctoral degree in nursing __
5) What is your current employment status?
Full-time (36+ hrs/week) _____
Part-time ____
Per Diem nurse ____
Agency nurse ____
Traveler nurse ____
Retired (more than 3 months) Yes ____

No _____

6) What is your current work setting?
Inpatient oncology unit ___
Outpatient oncology unit ____
Other______________________________________
7) Total number of years working as a registered nurse. ______________years
8) Total number of years working as an oncology nurse. ________years
9) Are you certified in oncology nursing?
Yes _____ No ____

10) Have you taken End of Life and Palliative Nursing Education (ELNEC) course?
Yes _____ No ____

11) Which of the following statements best describes your highest basic education in health care ethics?
Ethics content integrated throughout nursing program of study ___
Separate Ethics Course ___
No ethics content ___
12) Have you taken any continuing education courses in health care ethics?
Yes ____ No ____
13) Have you ever requested or participated in a consultation with the ethics committee to deal with a morally
distressing clinical situation?
Yes ____ No ___
14) If you experienced a morally challenging situation describe how you took a stand for your patient; what was the
outcome of your stand; how did that make you feel?
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Abbreviated Email Announcement
I am asking you to assist in an online survey, being conducted as part of a
research project under the supervision of Dr. Norma Conner and Dr. Susan Chase at the
University of Central Florida in fulfillment of my doctoral degree (PhD) requirements.
You are being requested to contribute because you have been identified as an oncology
nurse with adult patient oncology experience.
The purpose of the study is to obtain information regarding Oncology Nurses’
perceived distress and identify what actions are taken by nurses in clinical situations
when caring for patients with serious illness and terminal conditions. By participating,
you will be helping to provide insight into this essential undertaking. The results will be
presented at nursing conferences and submitted for publication in oncology journals.
The survey is anonymous; no names or personal identifying data is necessary,
and we will not divulge information that will distinguish you as a participant. If you
choose to participate, approximately 15 minutes of your time is required. Involvement is
voluntary and responses are confidential. You should try to answer all the questions.
However, you do not have to answer a question you are unsure about or that makes you
feel uncomfortable. To complete the online survey please use this link
https://ucf.qualtrics.com/ControlPanel/?ClientAction=ChangePage&s=MySurveysSectio
n&ss=&sss= or copy and paste the URL into your internet browser. Completion of the
survey will serve as consent.
Sincerely,
Lolita Melhado, MSN, ARNP, FNP-BC
University of Central Florida
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EXPLANATION OF RESEARCH
Title of Project: Evaluating Moral Distress, Moral Residue, and Moral Courage in the Oncology
Nurses
Principal Investigator: Lolita Melhado, MSN, ARNP, FNP-BC

Other Investigators: N/A

Faculty Supervisor: Susan K. Chase, EdD, RN, FNP-BC and Norma E. Conner, PhD, RN
You are being invited to take part in a research study because you have been identified as an
oncology nurse with adult patient oncology experience. ONS did not contribute to the
development of this survey or research study. Sharing of this request does not imply ONS’s
involvement or endorsement of the survey or research study. All research on human volunteers
has been reviewed by an Institutional Review Board. Participation in this survey constitutes your
informed consent. Whether you take part is up to you.

The purpose of this study is twofold: (1) the researcher will examine the relationship between moral
distress, moral residue, and moral courage in oncology nurses working in the adult inpatient and
outpatient settings, and (2) the researcher will identify which oncology nurse characteristics are
predictors of moral distress and moral courage; and specifically what oncology nurse actions
indicate moral courage.
Participants who choose to participate in this anonymous on-line survey will access the
study link to the Qualtrics on-line Survey. The participant may access the on-line survey from his or
her individual computer or smart phone and will be prompted to read and accept this consent. No
names or identifying coding will link the subject to the survey. Completion of the on-line survey
will serve as written consent.
The on-line survey consists of three parts. The first part of the survey consists of
demographic data. You will complete 13 demographic items consisting of brief questions (i.e., age,
gender, level of education, total years education, etc) and one open-ended question intended to
ascertain what action were taken by the nurse to demonstrate moral courage. Next, you will read the
instructions for the Moral Distress Scale-R (MDS-R) and respond to 21 items indicating the level of
frequency and level of disturbance experienced in each clinical situation. The items are measured on
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two dimensions as 0 – 4 (none to very frequent) and 0-4 (no disturbance to great disturbance). You
may also write in two additional clinical situations if they choose and rate the level of frequency and
disturbance. Additionally the scale contains two closed ended questions (yes or no responses) to
evaluate moral residue. The final scale, Moral Courage Scale is a 15-item 7 point scale.
Respondents are instructed to read the instructions and respond to each item ranging from 1 (never)
to 7 (always).
The time needed to complete the Qualtrics on-line Survey is 15 minutes. Data is collected a
single time. The time in the study ends when the survey is completed.
You must be 18 years of age or older to take part in this research study.

Study contact for questions about the study or to report a problem: If you have
questions, concerns, or complaints: Lolita Melhado at 239-314-4126 or
lolita.melhado@knights.ucf.edu. You may also contact my faculty supervisors: Dr. Susan chase
(407-823-6274; susan.chase@ucf.edu) or Dr. Norma Conner (407-823-2630;
norma.conner@ucf.edu).
IRB contact about your rights in the study or to report a complaint: Research at the
University of Central Florida involving human participants is carried out under the oversight of the
Institutional Review Board (UCF IRB). This research has been reviewed and approved by the IRB.
For information about the rights of people who take part in research, please contact: Institutional
Review Board, University of Central Florida, Office of Research & Commercialization, 12201
Research Parkway, Suite 501, Orlando, FL 32826-3246 or by telephone at (407) 823-2901.
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From: Ann B Hamric [mailto:abhamric@vcu.edu]
Sent: Tuesday, February 26, 2013 11:03 PM
To: Melhado, Lolita
Cc: Alison Crehore
Subject: Re: Permission to use MDS-R
Dear Ms. Melhado,
Thank you for your interest in the Moral Distress Scale – Revised (MDS-R). There are
six versions of this scale: nurse, physician and other healthcare professional versions for adult
settings (including ICUs and other inpatient units), and parallel versions for healthcare providers
in pediatric settings.
I am happy to grant permission to use any of the MDS-R scales, but require agreement to
the following condition: Individuals wishing to use the MDS-R must agree to share their
data with Drs. Hamric and Corley in an SPSS file in order to further the psychometric
testing of the instrument.
If you agree to adhere to this condition for use, I am happy to give you permission to use
the scales. I have attached the adult nurse version. Let me know if you are interested in the nurse
pediatric version as well. If you decide to change items for particular specialty purposes, Dr.
Corley and I request that you keep us informed of the changes you make and the results you
obtain.
Best wishes for success with your research!
Ann Hamric
**********************************************
Ann B. Hamric, PhD, RN, FAAN
Associate Dean of Academic Programs
Professor, School of Nursing
Virginia Commonwealth University
1100 East Leigh Street, Room 4009b
P.O. Box 980567
Richmond, VA 23298-0567
Phone: 804.828.3968
Fax: 804.827.5334
abhamric@vcu.edu
*********************************************
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Table 47
Coding Category Final Categories and Process of Analysis
Content category

Themes

Taking a Stand/Moral Courage Example

Moral agency – a predisposition
toward moral behavior and
possessing a persistence of will to
engage as a moral agent (Sekerka,
Bagozzi, & Charnigo 2009)

Supporting











Risk-taking






Advocacy





Importance of advocating; supporting patient autonomy. Supporting the patient was
the right thing to do. The patient was my first concern.
Ensuring she received the very best care possible; to help the other staff appreciate
that this was her will and her right.
Supporting patient's decision.
Advocating and supporting patient autonomy.
It did not seem like much, but it was all I could do. Explaining each physician's role
in her treatment and reassuring her that I had heard everything the doctors had said
and could help her explain to family members due to arrive that evening. Encouraging
her to write down questions as she thought of them so she could be ready for the
doctors when they came in the next morning.
Although this was a very tragic situation and very stressful for the staff caring for the
mother (unresponsive) as the clinical specialist it was my job to ensure she received
the very best care possible and help the other staff appreciate that this was her will and
her right.
Allowing the patient to express his feelings and make a decision by himself.
Respecting the decision.
Confronting physician responsible for providing unwanted continuing care at end of
life; I was influenced by my role as patient advocate and my refusal to participate in
unethical treatment
Confronting a physician for not making a patient a no code
Reporting the concern to IRB.
Supporting patient's end of life decisions, stopping treatment although family was
completely against this decision
Fighting for my patient’s best. Informing family of current status, level of discomfort,
providing excellent care and comfort to the patients.
Allowing the patient to participate in decisions; listening to their voice; working my
best to communicate to the physician(s) current status; assessment. Doing everything
possible for my patients in caring and respectful manner.
Explaining to the patient that she has a right to dictate her care, if she didn't want this
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Content category

Themes

Taking a Stand/Moral Courage Example


Multiple values – the ability to
draw on multiple value sets in
moral decision making and to
effectively sort out and determine
what needs to be exercised, and to
hold firm to beliefs despite
external concerns or demands
(Sekerka et al., 2009)

Enlarging the Circle
for Decision Making














Beyond Personal
Values



type of treatment, she didn't have to take it. The patient didn't want it; walked her back
to the physician side so she can talk to him. I believe patients have a right to decide
what kind of care they receive. That is what made me take action with this patient, or
any patient.
Advocating for my patient is my number one priority.
Supporting the patient decision. I contacted the patient’s medical doctor who agreed
to take over the patient’s end of life care.
We ended up consulting a physician who was of the patient's nationality to speak with
family, then with patient, and the patient gave informed consent/ received the
treatment that he needed with full understanding
Requesting an ethics consult and we were able to get an oncologist on board who
ordered appropriate pain medication for the patient
Recommending that the family get a 2nd opinion from another Med Oncologist. They
agreed----they simply needed affirmation that what they suspected was true.
Spending my own time researching where he had been who he had been with and over
a period of days was able to identify significant others for him. They were able to
come see him and contact his children before he was taken off life support. I chose to
give it my best effort so he wasn't alone and then lost.
Recommending ethics committee involvement and tried to persuade family that
patient's pain was real and required analgesics that would be given cautiously.
Educated family on addiction and on negative impact of uncontrolled pain on patients.
Informing the Attending MD of patient's expressed wishes. MD insisted on starting
treatment. I initiated a consult to Ethics Committee as I was acting as my patient's
advocate. I knew it was my role as a nurse to take the actions that I did. For that, I
am grateful that I was able to be this man's advocate
Meeting with the physician; supporting the patient’s choice to decline treatment.
Stopping the chemotherapy authorization until this was resolved
Having a care conference with social worker, case manager, medical doctor, sisters,
husband and the patient. Supporting the patient by sharing her story, her dreams of
spending time with her girls/husband at home and not in a hospital
Corralling the various medical staff and nursing staff caring for him, plus social
service and requested an Ethics Committee meeting. The recommendation was to
keep him in the US in a facility that could safely care for him and attempt to get a visa
for his mother or a sibling.
Putting my personal beliefs aside and encouraging the family to communicate.
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Content category

Themes

Patient Autonomy

Patient Empowerment

Taking a Stand/Moral Courage Example



Respecting the patients’ decision even if I don’t agree.
Spending time with patient, educating her on disease type and all possible treatment
options and possible side effects. Felt she was making an educated decision and
although I personally did not agree with her, I felt it was her right to make this
decision




Wanting the patient’s wishes to be met not family's wishes
Encouraging her to talk to her family and her doctor about what she wanted, and
reminded her it was her choice as to how much she wanted to undertake. I talked with
her about it first because she brought it up, she seemed frail and tired and scared, and I
sensed she might not have made her own feelings clear to her family. She ended up
going through treatment



Agreeing and participating in a family conference with the patient, explaining there
were no treatments available that could provide cure for this disease in the setting of
failing a bone marrow transplant. I believed I empowered the patient to make the
decision he desired.
Asking "which of you want to see your loved one die in pain and suffering" This after
days of explaining the dying process. I told them that death was imminent and it was
not a matter of the choice for stratification or full code, it was a choice of how she
should die, with or without pain. After days of cajoling, I could no longer feel for the
family because it was my responsibility to advocate for the pt



Endures threat – facing an ethical
and moral difficulty, both
perceived and real danger or
threat, with endurance (Sekerka et
al., 2009)

Fighting for my
Patient in Face of
Consequences in a
Complex System








Refusing to give therapy and not getting the patient’s consent. I went to the physician
and his nurse and stated the patient needed to come back to an exam room to discuss
treatment side effects prior to infusion. The physician was trying to push to continue
d/t time constraints and I pushed back and said it wasn't appropriate.
Speaking with a more senior physician on staff and he arranged for the infant to spend
a few hours with the young mother on the unit.
Calling the Doctor and told him she refused and he said I was crazy, she did not even
know what was going on. I did not insert the tube and got the head of Ethics to come
and he agreed that patient was refusing the feeding tube.
Approaching a physician who continued to aggressively treat a terminally ill patient.
Encouraged palliative care and dialogue with family. Dr. was not happy. My
experience and strong patient advocate philosophy helped.
Calling the physician and refusing to give drugs. Physician called administration. I
was supported by my nurse manager in the a.m.
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Content category

Themes

Taking a Stand/Moral Courage Example






Initiating an Ethics panel meeting and the decision to proceed with disconnecting the
ventilator was made. The physician volunteered to come in and turn off the machine
himself in view of the stance by the staff (they said they would quit the job rather than
follow the order).
Calling Legal counsel as this was an emergent situation. I wanted to support the
written and verbal desires for care communicated by both the patient (when able) and
the wife as the durable power of attorney. Legal consult done with physician. Patient
was not placed on ventilator. However, the physician came by my office and
physically knocked office door off hinges wanting to know where I was. I was not
present. Security was called by my office mate. Physician was escorted out of
hospital.
Contacting legal department to come to discuss situation with patient's durable power
of attorney. Dr. was instructed to abide by the wishes of patient/patient's durable
power of attorney

Conquering Fear

Goes beyond compliance – one
who not only considers the rules,
but reflects on their purpose, goes
beyond compliance-based
measures to consider what is
right, just, and appropriate
(Sekerka et al., 2009)

Sharing Information:
Getting to meaning



Taking a deep breath, praying and answering according to patients conditions and
needs



Collaborating with our SW, the other nurse, the NP in our palliative care division, and
the physician. I'm usually quick on my feet, but this was delicate: didn't need the
family getting into an uproar, but at the same time, there was no reason to hide this
diagnosis! If the patient had flat-out said "I don't want to know. Just treat me." fine.
But he hadn't.
Talking honestly about her wishes, what she wanted and how she felt about going to
the in-patient Hospice facility. What was going through my head was how not
terminal she looked. (I have had loads of experience with terminal patients and this
was not the feeling I was getting from her.) I asked her if she had spoken to the
covering medical oncologist. We talked and laughed and cried that afternoon/evening.
Finally I asked her frankly, "what do you want to do? Do you have any desire to try
the chemotherapy again?" I mentioned that either decision was hers, but if she wanted
me to, I would call her medical oncologist and see if we could try one more round of
treatment. I would do whatever it took to make her comfortable and peaceful. I also
set in motion a lot of very upset administrators, nurses and supervisors who called me
on the carpet for interrupting what was their plan to transfer her to the in-patient
Hospice. I argued that I was advocating for my patient, whom I knew very well and
did not feel she was entirely hospice appropriate at this time. I very nearly lost my job
for going over the heads of the doctors, charge nurse and supervisor, but I did not
back off advocating for her and I had given her the option of proceeding to hospice
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Content category

Themes

Taking a Stand/Moral Courage Example



Tricky Situation





Moral Goal – a drive for task
accomplishment that includes the
use of virtues (e.g., prudence,
honesty, and justice) throughout
the decision making process to
achieve a virtuous outcome
(Sekerka et al., 2009)

Truth Telling
Protecting my Patient





care or trying a drug that had worked well for her in the past. I went with my
experience and instinct, as it has served me well over my oncology nursing.
I sat down with him and asked him why he wanted to continue with therapy and what
he expected to achieve with doing so. The patient had the understanding that he could
be cured. I gently explained that the goal of therapy in his condition was palliation
but if receiving therapy caused him more distress and decreased QOL he may want to
consider forgoing therapy. The patient started to cry and definitely did not want
therapy. I explained to his MD the patient's understanding. The physician's response
to me was that he had been told!
Telling the physician as nicely as I could that I had his number and I knew he was on
call the weekend and I was working all weekend and I would be calling on an hourly
basis to continue to advocate for the patient who was moaning and writhing in the bed
but not awake enough to tell me his pain level.
I found myself coming between my patient and administration and standing up to
administration to allow my patient to come to terms with this very grave condition.
They backed off.
Discussing with the patients their thoughts on what they wished for their care if they
were to not recover from their disease and if they suddenly stopped breathing. I
explained to the patient normally in the situation of a patient that becomes
unresponsive it is protocol to begin CPR and in the event the patient did not breathe
on their own they would be intubated, and hooked up to a breathing machine to keep
them alive. I took a stand for my patient helping them discuss what their end of life
wishes were.
I was very honest and candid with them and suggested some questions for them to ask
the physician team.
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Announcing the Final Examination of Lolita W. Melhado for the degree of Doctor of Philosophy
Date: March 16, 2016
Time: 1:30 pm
Room: 328
Title: Evaluating Moral Distress, Moral Distress Residue and Moral Courage in Oncology Nurses
Purpose: To examine relationships between moral distress, moral distress residue, and moral courage and to
determine which nurse characteristics are predictive of moral distress and moral courage.
Methods: The study used a mixed methods cross-sectional correlation design and qualitative content analysis to
investigate oncology nurses’ characteristics and relationships between moral distress, moral distress residue, and
moral courage. A convenience sample of 187 oncology nurses working in inpatient and outpatient settings was
recruited through the national Oncology Nursing Society in the Southeastern United States. A power analysis
determined a sample of 159 subjects was required to detect statistical significance. Hamric’s 21-item Moral Distress
Scale-Revised (MDS-R) and Sekerka et al. 15-item Professional Moral Courage Scale (PMCS) supplemented with
written examples of moral courage were used for data collection. Descriptive statistics, independent-samples t test,
Pearson correlation, ANOVA, and multiple regressions analyses were used to evaluate data.
Findings: MDS-R scores were not predictive of PMCS scores. No statistically significant differences were found
between nurses’ characteristics (age, education level, certification, ELNEC training) and MDS-R. Though nurses
with a BSN had higher Moral Distress scores compared with other levels of education, none were predictors of
MDS-R. ANOVA results indicate a marginal but not significant difference of the MDS-R score among the nurses
with different basic ethics education (p = .067). Nurses working in adult inpatient settings had significantly higher
MDS-R than those in outpatient settings. Nurses who had moral distress residue by virtue of leaving a previous job
(26%) and those who considered leaving (28%) reported statistically significantly higher mean Moral Distress levels
than those who had not considered leaving. Nurses (17%) currently considering leaving their jobs due to the way
patient care was handled at their institutions had the highest Moral Distress mean scores and the lowest Professional
Moral Courage scores. Work setting and having left a previous job were weak predictors of MDS-R, accounting for
11.6% of the moral distress score variance (p = .013) compared with 4.4% when work setting was a single predictor
(p = .014). Total years’ oncology experience was a weak predictor of PMCS, accounting for 2.5% or an
inconsequential amount of the variance (p = .043). Moral courage was displayed in major areas of supporting the
patient, risk taking, advocacy, enlarging the circle for decision-making, putting aside personal beliefs, respecting
patient autonomy, empowering the patient, fighting for the patient in face of consequences in a complex system,
sharing information, getting to the meaning, handling tricky situations, protecting the patient and truth-telling
Discussion/Implication: Despite experiencing levels of moral distress, oncology nurses demonstrate support and
respect for patients’ decision-making and autonomy. Ethics education derived from clinical practice can provide an
opportunity for open discussion for nurses to create and maintain morally acceptable work environments that enable
them to be morally courageous. This research underscores the presence of moral distress and moral distress residue
among oncology nurses and the importance of finding ways to lessen moral distress and strengthen moral courage in
nurses.
Outline of Studies:
Major: Doctor of Philosophy Nursing

Committee in Charge:
Dr. Susan Chase, Chair
Dr. Norma Conner, Co-Chair
Dr. William Haley
Dr. Victoria Loerzel
Dr. Nizam Uddin

Educational Career:
AAS, Queens Borough Community College, 1993
BSN, Florida Gulf Coast University, 2001
MSN, Florida Gulf Coast University, 2007

Approved for distribution by Dr. Susan Chase, Committee Chair and Dr. Norma Conner, Co-Chair on February 24,
2016. The public is welcome to attend.
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VITA

Lolita Winifred Melhado
1993

Associate of Applied Science, Nursing, Queens Borough Community College

1993-1994

Registered Nurse, Winthrop University Hospital, Mineola, New York

1995-1997

Registered Nurse, Lee Memorial Health System, Fort Myers, Florida

1997-2000

Infection Control Coordinator/Risk Manager, Southwest Regional Medical
Center, Fort Myers, Florida

2001

Bachelor of Science, Nursing, Florida Gulf Coast University, Estero, Florida

2000-2004

Registered Nurse, Lee Memorial Health System, Fort Myers, Florida

2004-2007

Clinical Educator, Lee Memorial Health System, Fort Myers, Florida

2007

Master of Science, Nursing, Family Nurse Practitioner, Florida Gulf Coast
University, Estero, Florida

2007-Present Palliative Care ARNP, Lee Memorial Health System, Fort Myers, Florida
2010-2016

Doctoral Studies in Nursing, University of Central Florida, Orlando, Florida

2010

Research Fellowship, University of Central Florida, Orlando, Florida

2011-2014

President, Southwest Florida Chapter Hospice and Palliative Nurses, Fort Myers,
Florida

2014

Research Advisory Council, Hospice and Palliative Nurses Association

2014

Featured biography and photo, Journal of Hospice & Palliative Nursing

2016

National Coalition for Hospice and Palliative Care: Advance Care Planning Work
Group

2016

Doctor of Philosophy, Nursing, University of Central Florida, Orlando, Florida
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